Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Ribosome,-0.8183032268681654,-2.936527795357649,0.0,0.0,0.0,93/127,11.80%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPS3A1;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPL13;RPS27A;RPS8;RPL7;RPL24;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL17;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPS18;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;MRPL36;RPL32;RPL35A;MRPL9;MRPS16;MRPL18;RPL36AL;MRPS21;RPL10;RPL36A;MRPL30;MRPL14;MRPL23;RPS26;MRPS14;RPLP0;RPS13;RPS19;MRPL19;MRPS2;MRPL11;RPS27L;MRPL33
gsea,Parkinson disease,-0.7342791935375971,-2.8032814445143863,0.0,0.0,0.0,80/109,17.68%,UBB;SLC25A4;ATP5B;COX6C;CYC1;COX8A;UQCRQ;NDUFA1;NDUFA3;NDUFS5;PARK7;COX4I1;COX5B;ATP5H;COX6B1;ATP5O;SLC25A5;NDUFA4;ATP5J;UQCRB;VDAC1;COX5A;ATP5D;ATP5G2;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB11;ATP5E;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;ATP5G3;COX7A2;COX7B;UBE2J1;NDUFS8;CYCS;NDUFS7;UQCR11;UQCRC2;ATP5G1;PINK1;ATP5A1;NDUFA7;ATP5C1;VDAC3;GNAI1;NDUFB8;UBA1;NDUFV2;NDUFA8;SNCA;NDUFC1;NDUFV1;NDUFC2;UCHL1;GNAI2;NDUFA12;NDUFB6;SLC18A2;VDAC2;NDUFA10;NDUFB4;NDUFA5;NDUFS6;NDUFB5;SDHA;SDHD;PRKACB;NDUFAB1;UQCRFS1;SDHB;GPR37;NDUFA9
gsea,Oxidative phosphorylation,-0.746857484217629,-2.7857898447863207,0.0,0.0,0.0,75/103,16.29%,ATP6V0C;ATP5B;COX6C;ATP6V1D;CYC1;COX8A;UQCRQ;ATP6V1A;NDUFA1;NDUFA3;NDUFS5;COX4I1;COX5B;ATP5H;ATP6V1G2;COX6B1;ATP5O;COX17;ATP6V0E2;NDUFA4;ATP5J;UQCRB;COX5A;ATP5D;ATP5G2;COX7C;COX7A2L;UQCR10;COX6A1;ATP5K;NDUFB11;ATP5E;NDUFS2;NDUFB3;NDUFA2;ATP6V0B;UQCRH;UQCRC1;NDUFA13;NDUFB10;ATP5G3;COX7A2;COX7B;NDUFS8;ATP6V1F;ATP5L;NDUFS7;UQCR11;UQCRC2;ATP5G1;ATP5A1;NDUFA7;ATP5C1;NDUFB8;NDUFV2;NDUFA8;NDUFC1;NDUFV1;NDUFC2;ATP5J2;ATP6V1C1;NDUFA12;NDUFB6;NDUFA10;NDUFB4;ATP6V1E1;NDUFA5;ATP6V1B2;NDUFS6;NDUFB5;SDHA;SDHD;NDUFAB1;ATP6V1G1;UQCRFS1
gsea,Alzheimer disease,-0.6527749631205535,-2.6579476238200317,0.0,0.0,0.0,74/135,14.20%,CALM1;CALM2;GAPDH;CALM3;ATP5B;COX6C;PPP3CA;APOE;CYC1;COX8A;UQCRQ;NDUFA1;NDUFA3;NDUFS5;COX4I1;COX5B;ATP5H;COX6B1;ATP5O;NDUFA4;ATP5J;UQCRB;COX5A;ATP5D;ATP5G2;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB11;ATP5E;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;ATP5G3;PSENEN;COX7A2;COX7B;NDUFS8;PPP3R1;CYCS;NDUFS7;UQCR11;UQCRC2;ATP5G1;PPP3CB;ATP5A1;NDUFA7;ATP5C1;APH1A;NDUFB8;RTN4;NDUFV2;NDUFA8;SNCA;NDUFC1;NDUFV1;CDK5R1;NDUFC2;BAD;NDUFA12;NDUFB6;NDUFA10;MAPK3;NDUFB4;NDUFA5;NDUFS6;NDUFB5;SDHA;GSK3B
gsea,Huntington disease,-0.6269974028630422,-2.6454414461198636,0.0,0.0,0.0,91/154,20.47%,SLC25A4;ATP5B;COX6C;CYC1;COX8A;UQCRQ;NDUFA1;NDUFA3;NDUFS5;COX4I1;CLTA;COX5B;ATP5H;COX6B1;ATP5O;SLC25A5;NDUFA4;ATP5J;BDNF;UQCRB;VDAC1;COX5A;AP2M1;ATP5D;ATP5G2;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB11;ATP5E;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;BAX;ATP5G3;COX7A2;COX7B;NDUFS8;POLR2G;POLR2F;SOD1;CYCS;NDUFS7;UQCR11;UQCRC2;ATP5G1;ATP5A1;NDUFA7;POLR2I;ATP5C1;VDAC3;NDUFB8;NDUFV2;NDUFA8;DNAL4;NDUFC1;NDUFV1;POLR2E;POLR2C;NDUFC2;NDUFA12;NDUFB6;VDAC2;NDUFA10;NDUFB4;NDUFA5;NDUFS6;NDUFB5;SDHA;TFAM;AP2S1;SDHD;NDUFAB1;UQCRFS1;DNAH7B;TBPL1;SDHB;NDUFA9;POLR2L;AP2B1;DCTN1;NDUFA11;CREB3L2;NDUFB7;NDUFB9;NDUFB2
gsea,Non-alcoholic fatty liver disease (NAFLD),-0.61114953187905,-2.5306582518190783,0.0,0.0,0.0,66/116,20.47%,COX6C;CYC1;COX8A;RAC1;UQCRQ;NDUFA1;NDUFA3;NDUFS5;JUN;COX4I1;COX5B;COX6B1;NDUFA4;UQCRB;COX5A;CDC42;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB11;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;BAX;COX7A2;COX7B;NDUFS8;CYCS;NDUFS7;UQCR11;UQCRC2;IRS2;NDUFA7;NDUFB8;NDUFV2;CEBPA;NDUFA8;NDUFC1;NDUFV1;NDUFC2;NDUFA12;NDUFB6;NDUFA10;XBP1;NDUFB4;NDUFA5;NDUFS6;NDUFB5;SDHA;GSK3B;SDHD;NDUFAB1;UQCRFS1;SDHB;NDUFA9;NDUFA11;NDUFB7;NDUFB9;PIK3R2;ADIPOR2;NDUFB2
gsea,Thermogenesis,-0.551256558562732,-2.471582356626379,0.0,0.0,0.0,97/182,20.47%,ACTB;ATP5B;GNAS;COX6C;CYC1;COX8A;UQCRQ;ACTG1;RPS6;NDUFA1;NDUFA3;NDUFS5;ACSL3;COX4I1;COX5B;ATP5H;COX6B1;ATP5O;COX17;NDUFA4;ATP5J;UQCRB;COX5A;ATP5D;ATP5G2;COX7C;COX7A2L;UQCR10;COX6A1;ATP5K;COA3;NDUFB11;ATP5E;NDUFS2;NDUFB3;NDUFA2;RHEB;UQCRH;UQCRC1;NDUFA13;NDUFB10;ATP5G3;COX7A2;COX7B;NDUFS8;ATP5L;NDUFS7;UQCR11;UQCRC2;ATP5G1;ATP5A1;NDUFA7;ATP5C1;HRAS;NDUFB8;COX20;NDUFV2;NDUFA8;NDUFC1;NDUFV1;NDUFC2;COX14;FGFR1;KRAS;ATP5J2;COA7;NDUFA12;NDUFB6;NDUFA10;NDUFB4;NDUFA5;AKT1S1;SIRT6;NDUFS6;NDUFB5;SDHA;SDHD;COX19;PRKACB;NDUFAB1;UQCRFS1;NDUFAF3;ADCY10;SDHB;SMARCE1;NDUFA9;SLC25A29;ATF2;NDUFAF2;NDUFA11;NRAS;CREB3L2;NDUFB7;COA5;NDUFB9;SMARCB1;NDUFB2
gsea,Nicotine addiction,0.721061309808568,2.4155840461785103,0.0,0.0,0.0,10/29,2.49%,GRIA3;GRIN2A;GRIA1;GRIN1;GABRA2;CACNA1A;GABRG3;GRIA4;CHRNA4;CACNA1B
gsea,Proteasome,-0.6469435264612315,-2.282117160361225,0.0,0.0,0.0,23/40,14.24%,PSMA7;PSMB5;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;POMP;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;ADRM1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Legionellosis,-0.6714574690033577,-2.241658938066524,0.0,0.0,0.0,11/30,9.11%,EEF1A1;HSPA8;ARF1;EEF1G;EEF1A2;HSPA2;RAB1B;IL18;CYCS;NFKB2;SAR1A
gsea,Cardiac muscle contraction,-0.5783064780981615,-2.2219521460213083,0.0,0.00013004191065006093,0.001,24/56,6.91%,ATP1B1;COX6C;CYC1;COX8A;UQCRQ;ATP1A1;COX4I1;COX5B;COX6B1;UQCRB;COX5A;COX7C;COX7A2L;UQCR10;COX6A1;ATP1A3;UQCRH;UQCRC1;COX7A2;COX7B;UQCR11;UQCRC2;ATP1B2;TPM1
gsea,Ferroptosis,-0.6433006564601134,-2.217560532191339,0.0,0.00011821991877278265,0.001,12/35,12.12%,FTH1;PRNP;ACSL3;FTL1;TRF;GPX4;PCBP1;MAP1LC3B;MAP1LC3A;VDAC3;GCLM;VDAC2
gsea,Taste transduction,0.6395039617514026,2.1484305140761744,0.0,0.000669781422550397,0.002,8/28,3.79%,CACNA1C;GABRA2;PDE1A;ASIC2;CACNA1A;GABBR2;ADCY8;CHRM3
gsea,Necroptosis,-0.5109385226834617,-2.0965703715957607,0.0,0.0007585778121253553,0.007,22/79,13.64%,FTH1;HSP90AB1;HMGB1;SLC25A4;PPIA;HSP90AA1;SLC25A5;SQSTM1;VDAC1;FTL1;GLUL;BAX;CHMP4B;SPATA2L;IFNGR2;VDAC3;CHMP2A;PARP1;CAMK2B;VDAC2;CHMP6;SPATA2
gsea,Phagosome,-0.5251953745511584,-2.0962415497739126,0.0,0.0007002256727310972,0.007,28/78,14.32%,ACTB;ATP6V0C;TUBA4A;TUBA1A;ATP6V1D;TUBB2A;RAC1;ACTG1;ATP6V1A;CALR;ATP6V1G2;ATP6V0E2;TUBB5;ATP6V0B;CANX;ATP6V1F;TUBB4A;TUBB4B;STX7;TUBB2B;LAMP1;SEC61G;ATP6V1C1;ITGAV;ATP6V1E1;ATP6V1B2;H2-M5;TUBA1B
gsea,Protein export,-0.6338272087608847,-2.0881347474173384,0.0,0.0007430966322860624,0.008,15/26,18.39%,SEC62;SRP14;SPCS2;SRP9;ARXES1;SEC61G;IMMP2L;ARXES2;SRPR;SPCS1;SRP19;OXA1L;SRP72;SEC61B;SEC11C
gsea,Spliceosome,-0.4651843923268444,-2.0784220820663273,0.0,0.0010403352852004874,0.012,63/126,26.33%,DDX5;HSPA8;ZMAT2;SNRPD2;WBP11;SNW1;SNRPG;HSPA2;SNU13;SF3B4;SF3B2;SNRNP27;SNRPF;PCBP1;MAGOH;RBM22;RBM8A;HNRNPA1;LSM2;U2AF1;BUD31;SART1;LSM7;SNRPD1;LSM4;PUF60;SRSF3;CDC40;CCDC12;HNRNPK;SNRPE;SNRNP200;LSM8;RBM17;PRPF38A;U2AF1L4;U2AF2;DDX39B;RBMXL1;NCBP2;SNRPB;PQBP1;TXNL4A;USP39;MAGOHB;RP9;PRPF19;CTNNBL1;LSM3;SLU7;PPIE;PHF5A;CWC15;SNRPC;SF3B6;DHX16;HNRNPC;XAB2;SYF2;LSM5;SNRPB2;PRPF18;EIF4A3
gsea,Gastric acid secretion,-0.5542372086967635,-2.068598076355087,0.0,0.0009753143298754569,0.012,19/51,15.12%,CALM1;ATP1B1;CALM2;ACTB;CALM3;GNAS;ATP1A1;KCNK2;ATP1A3;ATP1B2;KCNJ2;GNAI1;CAMK2B;GNAI2;SSTR2;MYLK3;ATP1A2;EZR;PRKACB
gsea,Mineral absorption,-0.6398345417790554,-2.0622983464173186,0.0,0.0009179428987063124,0.012,10/25,10.70%,FTH1;ATP1B1;ATP1A1;MT1;ATP1A3;FTL1;TRF;ATP1B2;ATP2B1;HMOX2
gsea,Antigen processing and presentation,-0.6021482836788133,-2.059925679596361,0.0,0.0008669460710004061,0.012,9/34,6.47%,HSP90AB1;HSPA8;HSP90AA1;CALR;HSPA2;CANX;PDIA3;CTSB;NFYB
gsea,Fluid shear stress and atherosclerosis,-0.48153639589236263,-2.0595804579491865,0.0,0.0008213173304214374,0.012,16/91,6.78%,CALM1;CALM2;HSP90AB1;ACTB;CALM3;HSP90AA1;RAC1;ACTG1;JUN;GSTM5;MEF2C;SQSTM1;SUMO2;GSTM1;PDGFA;GSTP1
gsea,Pertussis,-0.6022817074277967,-2.045731832348127,0.0,0.0009753143298754569,0.015,9/31,12.46%,CALM1;CALM2;CALM3;JUN;CFL1;CFL2;GNAI1;GNAI2;MAPK3
gsea,Rheumatoid arthritis,-0.6151270750229011,-2.037180605511871,0.0018975332068311196,0.0011765696677862657,0.018,14/30,16.03%,ATP6V0C;ATP6V1D;ATP6V1A;JUN;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;IL18;ATP6V1C1;ATP6V1E1;ATP6V1B2;TEK;ATP6V1G1
gsea,Citrate cycle (TCA cycle),-0.5968129032523588,-2.0180904356185057,0.0,0.0014186390252733919,0.023,12/28,17.95%,MDH2;IDH3B;MDH1;DLAT;SUCLG1;ACLY;SDHA;SDHD;IDH2;IDH3A;SDHB;IDH3G
gsea,Proximal tubule bicarbonate reclamation,-0.6814332147899511,-1.994926519205486,0.0,0.001696198834566012,0.029,5/17,6.16%,ATP1B1;ATP1A1;MDH1;ATP1A3;ATP1B2
gsea,Glycolysis / Gluconeogenesis,-0.5555257125387606,-1.947494242088504,0.002,0.002655022342438744,0.042,16/39,17.65%,GAPDH;ALDOA;PGAM1;PKM;ALDOC;TPI1;ENO2;DLAT;LDHA;PGK1;LDHB;PGAM2;G6PC3;PFKL;ENO1;AKR1A1
gsea,Collecting duct acid secretion,-0.6860094780499748,-1.9400702266736853,0.0,0.0029649555628213893,0.047,10/17,16.03%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1G1
gsea,Type II diabetes mellitus,0.5679755621456043,1.9216580433094612,0.0,0.013618888925191407,0.051,12/31,8.42%,CACNA1C;CACNA1E;CACNA1A;GCK;PRKCE;MAPK10;CACNA1B;PIK3R3;IKBKB;MTOR;PIK3CD;SOCS2
gsea,Mucin type O-glycan biosynthesis,0.6342450645108899,1.9167353847501576,0.0,0.011051393472081549,0.055,10/18,21.79%,GALNT18;GALNT14;GALNTL6;GALNT10;GALNT16;GALNT7;GALNT12;ST3GAL2;GALNT11;GALNT3
gsea,Kaposi sarcoma-associated herpesvirus infection,-0.422925970320066,-1.8978218419490653,0.0,0.004551466872752132,0.077,32/117,16.37%,CALM1;CALM2;UBB;CALM3;GABARAPL1;PPP3CA;RAC1;JUN;GNB2;GABARAPL2;GNG2;BAX;PPP3R1;CYCS;PPP3CB;ANGPT2;HRAS;GABARAP;GNG13;CDK4;KRAS;GNG10;MAPK3;ATG3;LYN;H2-M5;GSK3B;GNG3;HCK;GNG7;RCAN1;MAPK1
gsea,RNA transport,-0.41621136605838627,-1.8936592143731332,0.0,0.0045755487080577,0.079,53/142,23.11%,EEF1A1;EIF1;RAN;EIF4A1;EIF3C;EIF1B;EIF3F;EIF3H;EEF1A2;SUMO2;EIF4A2;PABPC4;EIF1AX;EIF3A;SAP18;POP5;MAGOH;EIF3I;RBM8A;EIF5B;EIF2S2;NUP50;PABPC1;RPP21;EIF5;DDX20;SEC13;EIF1A;NUP62;NUP37;EIF4EBP2;RPP38;EIF4G2;FMR1;NUP205;DDX39B;NUP35;EIF2B5;NCBP2;GEMIN6;MAGOHB;UPF3A;NUP107;GEMIN7;POP4;CLNS1A;TGS1;THOC7;SEH1L;UPF2;SUMO1;EIF3D;RPP25L
gsea,Salmonella infection,-0.48378472385631793,-1.8239649017354138,0.0,0.009567369140683055,0.157,15/50,8.03%,ACTB;PFN2;RAC1;ACTG1;JUN;CDC42;ARPC5L;ARPC5;WASL;ARPC2;IL18;IFNGR2;ARPC1A;PFN1;ARPC3
gsea,Glutathione metabolism,-0.5255090622875505,-1.8146329142788107,0.005474452554744526,0.010313668775694488,0.165,19/34,31.66%,GSTM5;GSTM1;SRM;GPX4;GSTP1;ODC1;GCLM;HPGDS;IDH2;NAT8F1;RRM2B;SMS;GSR;GSTM7;RRM1;GSTO1;GCLC;CHAC2;GSTM6
gsea,Alcoholism,-0.43997116928122687,-1.8145483085034233,0.0,0.009969879816504672,0.165,27/79,19.72%,CALM1;CALM2;H3F3B;H3F3A;CALM3;GNAS;GNB2;BDNF;GNG2;PPP1CA;HRAS;GNAI1;GNG13;KRAS;GNAI2;GNG10;SLC18A2;MAPK3;GNG3;PPP1CC;GNG7;MAPK1;NPY;PPP1R1B;ATF2;NRAS;CREB3L2
gsea,Glutamatergic synapse,0.41066592810545655,1.7995484084482232,0.0,0.03147972685986866,0.168,26/90,10.35%,GRIK4;CACNA1C;GRIA3;DLGAP1;GRIN2A;SHANK2;GRIA1;GRIN1;CACNA1A;GRIA4;ADCY8;ADCY2;GRM8;PLA2G4E;PRKCG;GRIK2;SHANK3;ADCY9;GRIK5;GRK3;TRPC1;GRM7;SHANK1;SLC1A1;DLG4;GRIK1
gsea,Bacterial invasion of epithelial cells,-0.45430956101300424,-1.799311761581417,0.001949317738791423,0.011703771958505487,0.198,12/56,8.03%,ACTB;RAC1;ACTG1;CLTA;CTNNA3;CDC42;ARPC5L;ARPC5;WASL;ARPC2;ARPC1A;ARPC3
gsea,Oocyte meiosis,-0.4358882759831731,-1.7951241764412846,0.0,0.011866324346818061,0.206,18/81,7.87%,CALM1;CALM2;CALM3;PPP3CA;YWHAG;YWHAH;YWHAB;YWHAE;PPP2R1A;PPP3R1;PPP3CB;SMC1A;RBX1;PPP2CA;PPP1CA;YWHAZ;ANAPC13;YWHAQ
gsea,Renin secretion,-0.47637690006797423,-1.770727532889266,0.003787878787878788,0.014422830090279483,0.254,10/41,7.97%,CALM1;CALM2;CALM3;GNAS;PPP3CA;CTSB;PPP3R1;PPP3CB;KCNJ2;GNAI1
gsea,Neuroactive ligand-receptor interaction,0.38180166246900193,1.7696304651673291,0.0,0.03482863397262064,0.216,23/123,8.28%,GRIK4;GRIA3;GRIN2A;GRIA1;GRIN1;GABRA2;GABRG3;GABBR2;GRIA4;CHRNA4;CHRM3;GRM8;GRIK2;RXFP1;GRID2;ADCYAP1R1;TRHR;GRIK5;GRM7;HTR2C;THRB;CHRNA7;GRID1
gsea,Cholesterol metabolism,-0.5329059837036838,-1.7673199186997672,0.0037105751391465678,0.014495848275403853,0.262,9/25,19.73%,APOE;NCEH1;VDAC1;VAPA;LRPAP1;VDAC3;VDAC2;ANGPTL3;PLTP
gsea,Protein processing in endoplasmic reticulum,-0.3877565579378849,-1.757873527445054,0.0019305019305019305,0.015196326130249979,0.274,41/146,17.53%,HSP90AB1;HSPA8;HSP90AA1;SEC62;CALR;DNAJA1;DNAJA2;HSPA2;CANX;BAX;UBE2J1;PDIA3;RBX1;DAD1;SSR3;SEC61G;SSR2;SAR1A;PDIA6;UBQLN2;BAG1;RNF5;ERP29;DDOST;SEC13;CRYAB;LMAN2;FBXO6;P4HB;XBP1;LMAN1;STUB1;VCP;RNF185;OS9;DNAJB2;HSPH1;SVIP;UBXN6;DNAJC1;STT3A
gsea,Cysteine and methionine metabolism,-0.5002785539752904,-1.7535017400274007,0.0019047619047619048,0.01524380174842381,0.28,9/35,11.27%,MDH2;MDH1;TST;SRM;MAT2B;LDHA;GCLM;GOT2;LDHB
gsea,Estrogen signaling pathway,-0.40965704058761265,-1.7381574285012351,0.003787878787878788,0.01746779178191359,0.316,11/85,3.86%,CALM1;CALM2;HSP90AB1;KCNJ3;CALM3;GNAS;HSPA8;HSP90AA1;JUN;KRT10;HSPA2
gsea,Mitophagy,-0.43492120205850265,-1.7172579463323612,0.0038910505836575876,0.020669819482272842,0.37,20/57,21.97%,UBB;GABARAPL1;JUN;SQSTM1;GABARAPL2;BNIP3L;TOMM7;CITED2;PINK1;HRAS;GABARAP;CSNK2B;KRAS;FIS1;USP30;FUNDC1;NRAS;TBK1;RAB7;MRAS
gsea,Drug metabolism,-0.4682099260194718,-1.7141922376879204,0.0074487895716946,0.02084004978366361,0.38,21/40,26.96%,NME7;NME2;GSTM5;GSTM1;GSTP1;ITPA;UCKL1;NME4;TK2;HPGDS;GUSB;IMPDH2;NME1;GMPS;HPRT;RRM2B;DUT;ADH5;GSTM7;RRM1;GSTO1
gsea,Human immunodeficiency virus 1 infection,-0.3730015234013229,-1.711739310887432,0.00196078431372549,0.02054662188270963,0.385,29/140,12.46%,CALM1;CALM2;CALM3;PPP3CA;RAC1;JUN;CFL1;CALR;ELOB;GNB2;GNG2;BAX;PDIA3;CFL2;PPP3R1;CYCS;PPP3CB;RBX1;HRAS;GNAI1;GNG13;GNA11;BAD;RNF7;KRAS;GNAI2;GNG10;SAMHD1;MAPK3
gsea,Tuberculosis,-0.40462793512422907,-1.7114792652017414,0.0019120458891013384,0.020108919841985033,0.387,35/90,26.92%,CALM1;CALM2;ATP6V0C;CALM3;PPP3CA;ATP6V0B;BAX;PPP3R1;IL18;CYCS;PPP3CB;IFNGR2;NFYB;LAMP1;CAMK2B;BAD;CEBPB;MAPK3;MAPK1;BCL10;HSPD1;RAB5A;JAK1;HSPA9;RAB7;TGFB2;RAB5C;IL10RB;RFXANK;RAB5B;H2-DMA;CREB1;ATP6AP1;LAMP2;AKT3
gsea,Synaptic vesicle cycle,-0.42912677134514704,-1.6943491330762255,0.009633911368015413,0.022881183802475006,0.424,20/60,16.03%,ATP6V0C;RAB3A;CPLX2;ATP6V1D;VAMP2;ATP6V1A;CLTA;ATP6V1G2;ATP6V0E2;AP2M1;ATP6V0B;ATP6V1F;SNAP25;ATP6V1C1;SLC18A2;ATP6V1E1;ATP6V1B2;AP2S1;NSF;ATP6V1G1
gsea,Salivary secretion,-0.44380152011907487,-1.694221517878928,0.0038461538461538464,0.022349063248929074,0.424,9/50,3.63%,CALM1;ATP1B1;CALM2;CALM3;GNAS;VAMP2;ATP1A1;CST3;ATP1A3
gsea,cGMP-PKG signaling pathway,-0.3758321734964522,-1.671307301197078,0.0,0.026895031520808053,0.483,34/111,16.37%,CALM1;ATP1B1;CALM2;SLC25A4;CALM3;PPP3CA;ATP1A1;SLC25A5;MEF2C;VDAC1;RGS2;ATP1A3;PPP3R1;PPP3CB;ATP1B2;IRS2;PPP1CA;VDAC3;GNAI1;GNA11;ATP2B1;BAD;GNAI2;ADRA2C;VDAC2;MAPK3;MYLK3;ADRB1;ATP1A2;PPP1CC;SLC8A2;MYL9;VASP;MAPK1
gsea,Prion diseases,-0.5249970238380863,-1.6682158328564227,0.016917293233082706,0.02751108865307956,0.496,14/22,32.66%,PRNP;NCAM2;BAX;SOD1;EGR1;MAPK3;PRKACB;MAPK1;NCAM1;MAP2K1;C1QB;PRKACA;HSPA1A;HSPA5
gsea,Vasopressin-regulated water reabsorption,-0.4659581639197993,-1.6597087398144903,0.013539651837524178,0.028948460109926608,0.515,19/35,26.02%,DYNLL1;GNAS;DYNLL2;VAMP2;ARHGDIA;DCTN6;STX4A;RAB11A;DCTN5;PRKACB;NSF;DCTN1;CREB3L2;RAB5A;RAB11B;RAB5C;DYNC2LI1;RAB5B;CREB1
gsea,Endocrine and other factor-regulated calcium reabsorption,-0.4651812585722744,-1.6532669967654237,0.016853932584269662,0.029743628499747977,0.528,13/35,15.12%,ATP1B1;GNAS;ATP1A1;CLTA;AP2M1;CALB1;ATP1A3;ATP1B2;ATP2B1;RAB11A;ATP1A2;AP2S1;PRKACB
gsea,Circadian entrainment,0.39552068795889095,1.6507114886310552,0.003952569169960474,0.09262120243268347,0.491,20/76,5.75%,RYR2;PRKG1;CACNA1C;GRIA3;GRIN2A;GRIA1;GRIN1;GUCY1A2;GRIA4;ADCY8;NOS1AP;KCNJ6;ADCY2;RYR3;CAMK2A;NOS1;PRKCG;CAMK2G;ADCY9;ADCYAP1R1
gsea,Glucagon signaling pathway,-0.39763955686826136,-1.6406795917247021,0.011406844106463879,0.032537569727234,0.569,18/70,15.49%,CALM1;CALM2;CALM3;GNAS;PPP3CA;PGAM1;PKM;PPP3R1;PPP3CB;LDHA;PPP4C;CAMK2B;LDHB;PGAM2;PHKG1;G6PC3;PRKACB;PFKL
gsea,Viral carcinogenesis,-0.3648653144820117,-1.630886425442057,0.0018248175182481751,0.03481938505568978,0.597,39/127,21.65%,YWHAG;YWHAH;RAC1;JUN;YWHAB;UBE3A;PKM;YWHAE;CDC42;SNW1;BAX;NFKB2;YWHAZ;HRAS;RANBP1;VDAC3;YWHAQ;GTF2B;DNAJA3;CDK4;BAD;KRAS;PSMC1;MAPK3;HNRNPK;LYN;H2-M5;PRKACB;EGR3;MAPK1;TBPL1;CDKN1B;ATF2;NRAS;CCND3;CREB3L2;PIK3R2;JAK1;GTF2H4
gsea,Long-term depression,0.41869524705232625,1.6215319748580732,0.006012024048096192,0.10297889371712353,0.571,12/49,6.79%,PRKG1;GRIA3;GRIA1;GUCY1A2;CACNA1A;RAF1;PLA2G4E;NOS1;PRKCG;GNA12;GRID2;IGF1R
gsea,RNA degradation,-0.4035818683857507,-1.6152105616863197,0.003952569169960474,0.03922064025205838,0.629,29/67,27.16%,PABPC4;BTG2;TOB1;ENO2;C1D;LSM2;PABPC1;ZCCHC7;LSM7;EXOSC4;LSM4;CNOT8;EXOSC3;LSM8;LSM1;PFKL;BTG1;ENO1;LSM3;BTG3;HSPD1;HSPA9;EXOSC9;MPHOSPH6;LSM5;EXOSC7;XRN1;CNOT6L;EXOSC2
gsea,Hypertrophic cardiomyopathy (HCM),0.3978664487230522,1.6038404160222997,0.00847457627118644,0.10723944776612467,0.629,7/52,2.42%,RYR2;CACNA1C;CACNB2;CACNA2D3;SLC8A1;PRKAG2;DMD
gsea,Calcium signaling pathway,0.3529416919385288,1.5931548217351617,0.0021929824561403508,0.10535661776717745,0.654,28/119,7.41%,RYR2;CACNA1C;GRIN2A;CACNA1E;GRIN1;SLC8A1;PDE1A;CACNA1A;ATP2B4;PHKG2;ADCY8;ATP2B3;CACNA1B;ADCY2;RYR3;ERBB4;CHRM3;CAMK2A;PHKA1;NOS1;PRKCG;CAMK2G;ADCY9;PLCG2;TRHR;ITPKB;MCU;HTR2C
gsea,Oxytocin signaling pathway,-0.36221986761203406,-1.5829705403967886,0.014141414141414142,0.05104782453361215,0.721,20/112,7.97%,CALM1;CALM2;ACTB;KCNJ3;CALM3;GNAS;PPP3CA;ACTG1;MYL6;JUN;EEF2;MEF2C;RGS2;PPP3R1;PPP3CB;PPP1CA;KCNJ2;KCNJ4;HRAS;GNAI1
gsea,Base excision repair,-0.48349169790839625,-1.5825515973342188,0.018018018018018018,0.05021618395871584,0.722,9/24,22.02%,HMGB1;PCNA;PARP1;APEX1;MPG;POLD4;POLL;TDG;POLD2
gsea,SNARE interactions in vesicular transport,-0.4490688899335027,-1.569226453235576,0.028680688336520075,0.05402873344366682,0.753,12/28,22.31%,VAMP2;STX16;STX7;BET1L;STX4A;VTI1B;SNAP29;VAMP3;GOSR1;STX1B;USE1;STX6
gsea,Retrograde endocannabinoid signaling,-0.3481218618055265,-1.5633548923759295,0.008016032064128256,0.0555567940499427,0.768,40/114,16.37%,KCNJ3;NDUFA1;NDUFA3;NDUFS5;GNB2;NDUFA4;GABRG2;GNG2;NDUFB11;NDUFS2;NDUFB3;NDUFA2;NDUFA13;NDUFB10;NDUFS8;NDUFS7;NDUFA7;GNAI1;NDUFB8;GNG13;NDUFV2;NDUFA8;NDUFC1;NDUFV1;NDUFC2;GNAI2;GNG10;NDUFA12;NDUFB6;NDUFA10;MAPK3;NDUFB4;NDUFA5;NDUFS6;NDUFB5;GNG3;PRKACB;GNG7;NDUFAB1;MAPK1
gsea,Arrhythmogenic right ventricular cardiomyopathy (ARVC),0.3906751554816616,1.5580880731047226,0.01037344398340249,0.1267713565227206,0.738,7/51,2.68%,RYR2;CACNA1C;CACNB2;CACNA2D3;SLC8A1;DMD;ACTN2
gsea,Human cytomegalovirus infection,-0.33541967271022427,-1.5502228677250616,0.007707129094412331,0.060906902151737635,0.808,33/149,16.37%,CALM1;CALM2;CALM3;GNAS;PPP3CA;RAC1;CALR;GNB2;GNG2;RHEB;BAX;PDIA3;PPP3R1;CYCS;PPP3CB;HRAS;GNAI1;GNG13;GNA11;ARHGEF1;CDK4;KRAS;CX3CL1;GNAI2;GNG10;ITGAV;MAPK3;H2-M5;GSK3B;GNG3;PRKACB;GNG7;MAPK1
gsea,Carbohydrate digestion and absorption,-0.4735686675736438,-1.5489388723432393,0.025145067698259187,0.06037660137324257,0.812,14/24,29.59%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;LCT;G6PC3;ATP1A2;HK1;PIK3R2;PIK3CB;AKT3;ATP1A4;AKT1;PIK3R1
gsea,ABC transporters,0.4546112563984948,1.5415129658889914,0.01859504132231405,0.13267253678352448,0.777,11/28,23.11%,ABCA5;ABCC5;ABCA3;ABCB8;ABCB1B;ABCD4;ABCA8B;ABCD3;ABCB9;ABCA4;ABCC8
gsea,Lysine degradation,0.39666433094001824,1.5404276232110927,0.023109243697478993,0.12329130339716153,0.779,18/49,20.41%,EHMT1;KMT2A;ACAT1;KMT2B;KMT2C;NSD1;SETDB1;COLGALT2;NSD3;EHMT2;CAMKMT;KMT2E;EZH2;SETD2;KMT5B;ALDH7A1;DHTKD1;SETMAR
gsea,Dilated cardiomyopathy (DCM),0.36886853173262,1.5151172768277297,0.027196652719665274,0.14118035556758723,0.833,21/57,18.20%,RYR2;CACNA1C;CACNB2;CACNA2D3;SLC8A1;ADCY8;DMD;ADCY2;ADCY9;CACNG3;SGCD;ADCY6;ITGA8;CACNA2D2;ITGA3;ITGB8;TTN;CACNG8;ADCY5;ITGA4;ATP2A2
gsea,Apelin signaling pathway,-0.34541238915032935,-1.5150007311508187,0.00784313725490196,0.07617718239658831,0.852,27/98,16.82%,CALM1;CALM2;CALM3;GABARAPL1;RPS6;GNB2;MEF2C;GABARAPL2;GNG2;EGR1;HRAS;GNAI1;GABARAP;GNG13;KRAS;GNAI2;GNG10;MAPK3;TFAM;MYLK3;GNG3;PRKACB;SLC8A2;GNG7;JAG1;MAPK1;ADCY10
gsea,Neurotrophin signaling pathway,-0.3427081094700218,-1.5122075910434307,0.013618677042801557,0.07625388588290642,0.852,12/103,4.40%,CALM1;CALM2;CALM3;BEX3;RAC1;ARHGDIA;JUN;BDNF;YWHAE;CDC42;MAGED1;BAX
gsea,Bile secretion,-0.42547660245228053,-1.5105517170494986,0.03571428571428571,0.07571084120050157,0.857,6/35,6.16%,ATP1B1;GNAS;ATP1A1;NCEH1;ATP1A3;ATP1B2
gsea,HIF-1 signaling pathway,-0.35874184862364056,-1.5088171623729032,0.02186878727634195,0.07544598182881035,0.859,23/73,20.10%,GAPDH;ALDOA;RPS6;ELOB;TRF;ENO2;RBX1;LDHA;IFNGR2;ANGPT2;PGK1;CAMK2B;MAPK3;TEK;EPO;PFKFB3;PFKL;MAPK1;CDKN1B;ENO1;ELOC;HK1;PIK3R2
gsea,Fructose and mannose metabolism,-0.4732888569302107,-1.5071807336429341,0.031835205992509365,0.0750192596028794,0.862,6/23,15.49%,ALDOA;PMM1;ALDOC;TPI1;PFKFB3;PFKL
gsea,Choline metabolism in cancer,0.3481554274636744,1.5055358740453737,0.009746588693957114,0.141145271778787,0.845,23/79,13.64%,SLC44A5;DGKG;MAPK10;RAF1;DGKH;PLA2G4E;PRKCG;PIP5K1B;PIK3R3;DGKB;CHKA;SP1;DGKQ;MTOR;PIK3CD;DGKI;SLC22A4;CHKB;SLC44A2;SOS1;AKT2;SLC22A21;DGKA
gsea,C-type lectin receptor signaling pathway,-0.36958951160255327,-1.505134770760998,0.023762376237623763,0.07475312412206729,0.865,9/65,7.58%,CALM1;CALM2;CALM3;PPP3CA;JUN;PPP3R1;PPP3CB;NFKB2;HRAS
gsea,Thyroid hormone synthesis,-0.40398882230720723,-1.4989643119265212,0.03125,0.07736461605022674,0.874,7/44,6.16%,ATP1B1;TTR;GNAS;ATP1A1;ATP1A3;CANX;ATP1B2
gsea,Glycerophospholipid metabolism,0.35236281792707014,1.49620113636795,0.020366598778004074,0.14157504819159017,0.863,19/68,16.26%,DGKG;DGKH;PLA2G4E;PLPP4;PCYT2;DGKB;CHKA;DGKQ;ETNK1;DGKI;CHKB;MBOAT2;PNPLA6;PGS1;DGKA;LPIN1;CDS1;PLA2G3;LYPLA2
gsea,Starch and sucrose metabolism,0.493472017909018,1.4952789018264414,0.060240963855421686,0.13391688560287057,0.866,5/18,10.08%,GCK;PGM2L1;PYGB;AMY1;AGL
gsea,Cellular senescence,-0.3339568966987351,-1.4937336535987655,0.01845018450184502,0.07912237501114645,0.884,22/116,16.37%,CALM1;CALM2;SLC25A4;CALM3;PPP3CA;SLC25A5;SQSTM1;VDAC1;RHEB;PPP3R1;PPP3CB;PPP1CA;HRAS;VDAC3;CDK4;KRAS;VDAC2;MAPK3;H2-M5;PPP1CC;RAD50;MAPK1
gsea,Melanogenesis,-0.37118713199929493,-1.4733417766402468,0.03007518796992481,0.09016906019997302,0.918,17/62,19.72%,CALM1;CALM2;CALM3;GNAS;HRAS;GNAI1;FZD3;CAMK2B;KRAS;GNAI2;MAPK3;GSK3B;PRKACB;MAPK1;NRAS;WNT16;CREB3L2
gsea,PI3K-Akt signaling pathway,-0.30226350021460224,-1.4641337809260437,0.008771929824561403,0.09473356157658984,0.937,54/201,21.10%,HSP90AB1;YWHAG;YWHAH;HSP90AA1;RAC1;RPS6;YWHAB;GNB2;BDNF;YWHAE;GNG2;VEGFC;RHEB;PPP2R1A;FGFR2;PDGFA;PPP2CA;CDC37;YWHAZ;ANGPT2;HRAS;YWHAQ;VTN;GNG13;VEGFB;CDK4;BAD;FGFR1;KRAS;GNG10;ITGAV;ITGA9;EPOR;MAPK3;PPP2R5D;GSK3B;TEK;G6PC3;GNG3;EPO;GNG7;MAPK1;CDKN1B;ATF2;PDGFB;HSP90B1;NRAS;CCND3;CREB3L2;PIK3R2;FGF5;NR4A1;CSF1R;JAK1
gsea,Viral myocarditis,-0.44004789342390555,-1.451172234444608,0.04990403071017274,0.10312129422145878,0.947,4/28,5.30%,ACTB;RAC1;ACTG1;CYCS
gsea,Dopaminergic synapse,-0.3337285331557105,-1.449405051322541,0.01818181818181818,0.10282872846549672,0.949,26/101,15.66%,CALM1;CALM2;KCNJ3;CALY;CALM3;GNAS;PPP3CA;GNB2;GNG2;PPP2R1A;PPP3CB;PPP2CA;PPP1CA;COMT;GNAI1;GNG13;CAMK2B;GNAI2;GNG10;SLC18A2;PPP2R5D;GSK3B;GNG3;PPP1CC;PRKACB;GNG7
gsea,Porphyrin and chlorophyll metabolism,-0.4557543581656769,-1.4486437822811395,0.05656934306569343,0.10194154995741733,0.949,8/21,26.59%,HMOX2;ALAD;GUSB;FXN;FECH;EPRS;CP;COX15
gsea,Amyotrophic lateral sclerosis (ALS),-0.39629344771030606,-1.4473628653904351,0.06261859582542695,0.10122833873316885,0.949,9/41,5.85%,NEFL;PPP3CA;RAC1;NEFM;BAX;SOD1;PPP3R1;CYCS;PPP3CB
gsea,Rap1 signaling pathway,-0.3191289323443059,-1.446172944899825,0.011472275334608031,0.10062679677625842,0.95,24/135,12.46%,CALM1;CALM2;ACTB;CALM3;GNAS;PFN2;RAC1;ACTG1;CDC42;VEGFC;FGFR2;PRKD1;PDGFA;PFN1;ANGPT2;HRAS;GNAI1;VEGFB;RALA;FGFR1;KRAS;GNAI2;TLN1;MAPK3
gsea,Axon guidance,0.30375778931489655,1.443945200017788,0.012244897959183673,0.18069214377248488,0.921,42/151,12.06%,SLIT1;PLXNA4;SLIT3;PAK3;NRP1;EPHB1;SEMA5B;ABLIM2;ABLIM3;NTNG2;PLXNC1;ROCK1;SRGAP2;RAF1;PLXNA2;CAMK2A;TRPC5;SEMA4D;PIK3R3;CAMK2G;PLCG2;DCC;NCK2;LIMK2;PTK2;TRPC1;TRPC6;SSH3;PIK3CD;PLXNA3;EPHB2;EFNB2;SSH2;EFNA1;L1CAM;SRGAP3;SMO;EPHA6;NEO1;LIMK1;SEMA6A;FYN
gsea,Morphine addiction,0.3425617538586683,1.442459431624346,0.032989690721649485,0.17312087190236838,0.923,15/73,6.25%,PDE2A;GABRA2;PDE1A;CACNA1A;GABRG3;GABBR2;ADCY8;PDE7B;KCNJ6;CACNA1B;ADCY2;PDE10A;PRKCG;ADCY9;GRK3
gsea,Tight junction,-0.3212496218742588,-1.43858428572177,0.019267822736030827,0.10453924706146564,0.958,25/106,18.98%,ACTB;TUBA4A;TUBA1A;RAC1;ACTG1;MYL6;JUN;MYL12B;CDC42;WASL;PPP2R1A;PPP2CA;ACTR2;CDK4;PCNA;TUBA1B;EZR;PRKACB;RDX;MYL9;VASP;MYH14;SYNPO;JAM2;MYL12A
gsea,Glycerolipid metabolism,0.3903801450446774,1.4364076504627405,0.059548254620123205,0.172133825595452,0.93,11/38,15.99%,DGKG;DGKH;PLPP4;DGKB;DGKQ;DGKI;MBOAT2;DGKA;LPIN1;MGLL;DGAT1
gsea,Protein digestion and absorption,-0.4117706731211715,-1.4352455137004845,0.03907637655417407,0.10551208723017957,0.958,9/32,15.24%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;SLC38A2;KCNJ13;SLC3A1;ATP1A2;SLC8A2
gsea,Aldosterone synthesis and secretion,-0.3492627783683128,-1.4352387549016794,0.04933586337760911,0.10410382144472445,0.958,12/70,10.58%,CALM1;ATP1B1;CALM2;CALM3;GNAS;ATP1A1;ATP1A3;PRKD1;ATP1B2;GNA11;ATP2B1;CAMK2B
gsea,Phospholipase D signaling pathway,0.3167549338014392,1.4272964438075184,0.01680672268907563,0.1745259021045606,0.94,23/106,8.55%,DGKG;ADCY8;ADCY2;DNM3;DNM1;RAF1;DGKH;GRM8;PLA2G4E;GAB2;PIP5K1B;PIK3R3;GNA12;ADCY9;PLCG2;DGKB;RAPGEF4;DGKQ;GRM7;MTOR;PIK3CD;DNM2;DGKI
gsea,Regulation of actin cytoskeleton,-0.312444632891652,-1.4272385077843392,0.02443609022556391,0.10842027563931081,0.96,46/145,22.48%,ACTB;TMSB4X;PFN2;RAC1;ACTG1;CFL1;MYL12B;CDC42;BRK1;ARPC5L;ARPC5;WASL;ARPC2;FGFR2;CFL2;PDGFA;PPP1CA;ARPC1A;PFN1;HRAS;ARPC3;ARHGEF1;PIP4K2A;FGFR1;KRAS;ITGAV;ITGA9;MAPK3;MYLK3;EZR;PPP1CC;RDX;MYL9;MYH14;MAPK1;VCL;WASF1;MYL12A;PDGFB;NRAS;PIK3R2;MYH10;FGF5;CXCL12;MRAS;ARPC4
gsea,Adrenergic signaling in cardiomyocytes,-0.316923788446818,-1.4227872861321598,0.03296703296703297,0.11007363305418974,0.962,24/104,15.12%,CALM1;ATP1B1;CALM2;CALM3;GNAS;PPP1R1A;ATP1A1;ATP1A3;PPP2R1A;ATP1B2;PPP2CA;PPP1CA;TPM1;GNAI1;ATP2B1;SCN1B;CAMK2B;GNAI2;MAPK3;PPP2R5D;ADRB1;ATP1A2;PPP1CC;PRKACB
gsea,Hippo signaling pathway,-0.3277974913524192,-1.4186771305493355,0.022727272727272728,0.11165026900098089,0.965,14/100,9.35%,ACTB;YWHAG;YWHAH;ACTG1;YWHAB;CTNNA3;YWHAE;PPP2R1A;CSNK1E;PPP2CA;PPP1CA;YWHAZ;YWHAQ;FZD3
gsea,Insulin secretion,0.34054388942990105,1.41332654735126,0.04294478527607362,0.18263721608544686,0.951,19/60,9.97%,RYR2;CACNA1C;GCK;ADCY8;PCLO;KCNN3;ADCY2;CHRM3;CAMK2A;PRKCG;KCNMA1;CAMK2G;ADCY9;ADCYAP1R1;KCNMB4;RAPGEF4;RIMS2;STX1A;KCNMB2
gsea,ECM-receptor interaction,0.3898645841891495,1.4129273988279647,0.05032822757111598,0.1750750396683907,0.951,15/33,23.74%,THBS3;LAMB1;LAMB3;TNR;LAMC1;RELN;COL4A1;SV2B;ITGA8;ITGA3;ITGB8;ITGA4;COL4A2;ITGA10;NPNT
gsea,Glycosphingolipid biosynthesis,0.4011161992191545,1.4127683547625804,0.06976744186046512,0.16800350682305792,0.951,6/32,8.61%,ST6GALNAC3;ST6GALNAC5;ST3GAL3;HEXA;HEXB;SEC1
gsea,Aldosterone-regulated sodium reabsorption,-0.4190484257250095,-1.4040195528786117,0.07471264367816093,0.12165587461711469,0.974,8/27,16.37%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;KRAS;MAPK3;ATP1A2;MAPK1
gsea,RNA polymerase,-0.42615900467061313,-1.3864635357645851,0.08914728682170543,0.13494728905179743,0.983,10/26,22.23%,POLR2G;POLR2F;POLR2I;POLR2E;POLR2C;POLR3D;POLR3H;POLR2L;POLR2J;POLR3A
gsea,Adherens junction,-0.33979561893134297,-1.3849569646131754,0.07045009784735812,0.13467465371696935,0.985,16/57,19.31%,ACTB;ACP1;RAC1;ACTG1;CTNNA3;CDC42;WASL;CSNK2B;FGFR1;MAPK3;PTPN1;SSX2IP;MAPK1;VCL;WASF1;CTNNA1
gsea,Cocaine addiction,-0.3874316440014705,-1.3817462167602694,0.072,0.13588576935087848,0.986,13/35,19.72%,GNAS;JUN;BDNF;GRM3;GNAI1;CDK5R1;GNAI2;SLC18A2;PRKACB;GRM2;PPP1R1B;ATF2;CREB3L2
gsea,Pyruvate metabolism,-0.396079082277108,-1.3749814307861965,0.05533596837944664,0.140350110884517,0.986,11/30,18.14%,MDH2;PKM;MDH1;DLAT;LDHA;GLO1;HAGH;LDHB;LDHD;ACYP1;GRHPR
gsea,NOD-like receptor signaling pathway,-0.3161822244511314,-1.3725606672626336,0.03525046382189239,0.14085262370410212,0.988,16/86,13.60%,HSP90AB1;GABARAPL1;HSP90AA1;JUN;VDAC1;GABARAPL2;CTSB;IL18;VDAC3;GABARAP;ATG12;ERBIN;VDAC2;MAPK3;NFKBIB;TXN1
gsea,Amphetamine addiction,-0.3698670244333692,-1.3716541619935694,0.09072978303747535,0.1400272716464049,0.988,9/49,6.31%,CALM1;CALM2;CALM3;GNAS;PPP3CA;JUN;PPP3R1;PPP3CB;PPP1CA
gsea,B cell receptor signaling pathway,-0.36061686347200833,-1.3714245708946955,0.08731808731808732,0.1385481815114061,0.988,19/46,23.88%,PPP3CA;RAC1;JUN;CD81;PPP3R1;PPP3CB;HRAS;KRAS;MAPK3;LYN;NFKBIB;GSK3B;MAPK1;BCL10;NRAS;PIK3R2;NFKBIA;PIK3CB;MAP2K1
gsea,Metabolism of xenobiotics by cytochrome P450,-0.44969278210126423,-1.3703412704062388,0.1043956043956044,0.13801075796547746,0.988,9/20,27.82%,GSTM5;GSTM1;GSTP1;HPGDS;CBR1;ADH5;GSTM7;GSTO1;DHDH
gsea,Biosynthesis of unsaturated fatty acids,-0.4111420935421667,-1.3644105234449664,0.09386973180076628,0.14176062995461816,0.989,8/27,27.35%,TECR;SCD1;SCP2;HACD4;SCD2;HSD17B12;ACOX1;ACOT3
gsea,p53 signaling pathway,-0.35539929380936836,-1.3523024027738928,0.08272058823529412,0.15149882590732097,0.99,23/48,34.47%,SESN1;RPRM;COP1;BAX;CYCS;PPM1D;CDK4;DDB2;SESN3;RRM2B;CCND3;CCNG2;SIVA1;BBC3;PTEN;CCND1;IGFBP3;SIAH1B;TSC2;GADD45B;SESN2;RCHY1;GORAB
gsea,MAPK signaling pathway,0.27429202077237785,1.3485536673410714,0.037267080745341616,0.24471134054301302,0.986,42/206,12.04%,CACNA1C;CACNA1E;CACNB2;CACNA2D3;FLNB;CACNA1A;TGFBR1;TAOK1;FGF10;RPS6KA2;CHUK;MAPK14;MAP4K4;MAPK10;CACNA1B;PTPRR;NF1;ERBB4;RAF1;PLA2G4E;NTF3;MAPT;MAP3K2;PRKCG;GNA12;FLT3;RASGRF2;IKBKB;IGF1R;PTPN5;FLNA;NTRK2;MAPKAPK2;CACNG3;MAP3K4;MAP3K7;EFNA1;RPS6KA6;MAP3K5;SOS1;MAP3K3;AKT2
gsea,Olfactory transduction,-0.38977880582218405,-1.3465925085590091,0.10727969348659004,0.15476448512420735,0.99,5/31,2.98%,CALM1;CALM2;CALM3;NCALD;RGS2
gsea,Cell cycle,-0.30950855926569154,-1.3431378174044672,0.043151969981238276,0.15636817300610661,0.991,30/88,31.11%,YWHAG;YWHAH;YWHAB;YWHAE;STAG1;SMC1A;RBX1;YWHAZ;ANAPC13;YWHAQ;CDK4;RAD21;PCNA;ANAPC11;GSK3B;ORC1;CDKN1B;CCND3;CDKN2D;TGFB2;E2F4;BUB3;CDC26;MCM6;CDC16;SMAD4;SMAD2;MAD2L2;SMC3;CCND1
gsea,PPAR signaling pathway,-0.37476737682617617,-1.3418870779688552,0.09636363636363636,0.1557359057433367,0.992,14/36,23.21%,ACSL3;SCD1;SCP2;DBI;FABP3;FABP5;FABP7;ILK;SCD2;UBC;PLTP;GK;ACSBG1;ACOX1
gsea,GnRH signaling pathway,-0.33677147296748317,-1.3375375199532273,0.08498023715415019,0.157986786449536,0.992,12/64,12.46%,CALM1;CALM2;CALM3;GNAS;JUN;CDC42;EGR1;HRAS;GNA11;CAMK2B;KRAS;MAPK3
gsea,Cholinergic synapse,0.31265092080445694,1.3362298286618077,0.05788423153692615,0.25446541892126234,0.989,25/81,13.58%,CACNA1C;CACNA1A;ADCY8;CHRNA4;KCNJ6;CACNA1B;ADCY2;CHRM3;CAMK2A;KCNQ2;PRKCG;PIK3R3;CAMK2G;ADCY9;KCNQ3;JAK2;KCNQ5;PIK3CD;CHRNA7;GNAO1;AKT2;FYN;ADCY6;CHRM2;CAMK2D
gsea,Human T-cell leukemia virus 1 infection,-0.2865894660451852,-1.3354136414508126,0.03508771929824561,0.15825960696100963,0.992,57/141,30.60%,SLC25A4;PPP3CA;RAN;JUN;CALR;SLC25A5;VDAC1;ETS2;CANX;BAX;PPP3R1;EGR1;PPP3CB;NFKB2;NFYB;GPS2;HRAS;RANBP1;VDAC3;CDK4;FDPS;KRAS;VDAC2;TLN1;MAPK3;H2-M5;ANAPC11;ELK4;IL1R2;PRKACB;MAPK1;TBPL1;ATF2;NRAS;CCND3;CREB3L2;PIK3R2;JAK1;TGFB2;NFKBIA;PIK3CB;MAP2K1;BUB3;H2-DMA;CREB1;B2M;CDC26;AKT3;CRTC2;CDC16;SMAD4;AKT1;PIK3R1;SMAD2;PRKACA;PTEN;SLC2A1
gsea,ErbB signaling pathway,0.3162820276547876,1.3349558050124324,0.08704453441295547,0.24652917693725349,0.989,16/74,7.92%,PAK3;MAPK10;NRG1;ERBB4;RAF1;CBL;CAMK2A;PRKCG;PIK3R3;CAMK2G;ABL2;PLCG2;NCK2;PTK2;MTOR;PIK3CD
gsea,Glioma,-0.3356199263384498,-1.334320645517284,0.09218436873747494,0.15771040227773347,0.993,11/62,13.27%,CALM1;CALM2;CALM3;BAX;PDGFA;HRAS;CDK4;CAMK2B;KRAS;MAPK3;DDB2
gsea,Renal cell carcinoma,-0.33365296797899363,-1.3320966572562545,0.0745697896749522,0.15803514299525828,0.994,31/59,34.50%,RAC1;JUN;ELOB;CDC42;RBX1;HRAS;BAD;KRAS;MAPK3;ARNT2;MAPK1;ELOC;PDGFB;NRAS;PIK3R2;TGFB2;PIK3CB;FLCN;MAP2K1;AKT3;PTPN11;RAP1A;AKT1;PIK3R1;EGLN2;PAK2;SLC2A1;PAK6;RAPGEF1;ARAF;VHL
gsea,Leukocyte transendothelial migration,-0.326652505763562,-1.3319512143177903,0.07056451612903226,0.156578588042089,0.994,18/62,21.57%,ACTB;RAC1;ACTG1;CTNNA3;MYL12B;CDC42;GNAI1;GNAI2;EZR;MYL9;VASP;JAM2;VCL;MYL12A;THY1;CTNNA1;PIK3R2;CXCL12
gsea,Prolactin signaling pathway,0.3385225980106023,1.3319193997504786,0.102,0.24270008261415454,0.992,12/49,12.04%,GCK;MAPK14;MAPK10;RAF1;PIK3R3;CCND2;JAK2;PIK3CD;SOCS2;SOS1;SOCS7;AKT2
gsea,GABAergic synapse,0.3227548611032886,1.3256962820383542,0.08471074380165289,0.24366186234160997,0.993,12/69,5.22%,CACNA1C;GABRA2;CACNA1A;GABRG3;GABBR2;ADCY8;SLC6A1;KCNJ6;CACNA1B;ADCY2;PRKCG;ADCY9
gsea,Progesterone-mediated oocyte maturation,0.31765236433158767,1.3227287089988071,0.07509881422924901,0.23996035765238888,0.993,19/66,12.91%,ADCY8;CDC27;RPS6KA2;MAPK14;MAPK10;ADCY2;RAF1;STK10;PIK3R3;ADCY9;CPEB4;MAD1L1;IGF1R;PIK3CD;RPS6KA6;ANAPC5;AKT2;ADCY6;RPS6KA1
gsea,Hepatitis C,-0.3065186324383992,-1.3223413742673966,0.0661625708884688,0.16465719037155138,0.995,27/90,24.46%,YWHAG;YWHAH;YWHAB;YWHAE;CD81;BAX;PPP2R1A;CYCS;PPP2CA;YWHAZ;HRAS;YWHAQ;CDK4;BAD;KRAS;MAPK3;PSME3;GSK3B;MAPK1;NRAS;TBK1;PIK3R2;JAK1;NFKBIA;PIK3CB;MAP2K1;TRAF2
gsea,Arginine and proline metabolism,-0.3730475162792231,-1.3203012001920105,0.0945945945945946,0.16507360902926102,0.996,9/34,22.40%,CKB;SRM;CKMT1;ODC1;GOT2;PYCRL;ARG2;SMS;CKMT2
gsea,Apoptosis,-0.3055280121322512,-1.3200561249684146,0.0692167577413479,0.16352441875581902,0.996,34/98,29.59%,ACTB;TUBA4A;TUBA1A;ACTG1;JUN;BAX;CTSB;CYCS;HRAS;CTSO;BOK;PARP1;BAD;KRAS;MAPK3;TUBA1B;MAPK1;DFFB;NRAS;PIK3R2;NFKBIA;PIK3CB;DIABLO;MAP2K1;TRAF2;HTRA2;DAXX;AKT3;ENDOG;BBC3;AKT1;CTSL;LMNA;PIK3R1
gsea,Pentose phosphate pathway,-0.4183491505254207,-1.3162225733469701,0.15581854043392504,0.16549133549326756,0.996,2/23,3.48%,ALDOA;ALDOC
gsea,Gap junction,-0.32009277045405327,-1.3144516829718726,0.08365758754863813,0.16566824399349842,0.996,19/66,16.37%,TUBA4A;GNAS;TUBA1A;TUBB2A;TUBB5;TUBB4A;TUBB4B;TUBB2B;PDGFA;HRAS;GNAI1;GNA11;KRAS;GNAI2;MAPK3;ADRB1;TUBA1B;PRKACB;MAPK1
gsea,Hedgehog signaling pathway,0.3616087643376022,1.3124130866518429,0.10736842105263159,0.24732219173981917,0.994,14/34,19.65%,LRP2;CSNK1G1;CCND2;GRK3;CDON;EVC2;SUFU;GPR161;SMO;BTRC;SMURF2;CUL3;BCL2;GRK2
gsea,Influenza A,-0.3028965369838596,-1.3089609812066518,0.07750472589792061,0.16930946798360874,0.996,27/86,25.65%,ACTB;HSPA8;ACTG1;JUN;VDAC1;HSPA2;IL18;CYCS;PML;IFNGR2;FDPS;MAPK3;NFKBIB;GSK3B;IVNS1ABP;DDX39B;MAPK1;ATF2;TBK1;PIK3R2;JAK1;HNRNPUL1;NFKBIA;PIK3CB;MAP2K1;KPNA2;H2-DMA
gsea,Epstein-Barr virus infection,-0.28761115680668925,-1.29965896495132,0.06272401433691756,0.17758927332075314,0.996,25/120,14.24%,RAC1;JUN;CALR;SNW1;PSMC3;SEM1;PSMC2;BAX;PDIA3;CYCS;NFKB2;PSMD2;PSMD4;PSMC5;CDK4;PSMD6;ADRM1;PSMC1;PSMD7;PSMC4;DDB2;LYN;H2-M5;NFKBIB;PSMC6
gsea,Long-term potentiation,-0.33551202254001017,-1.2868400388962253,0.12079207920792079,0.1896486210412956,1.0,15/56,16.37%,CALM1;CALM2;CALM3;PPP3CA;PPP1R1A;PPP3R1;PPP3CB;PPP1CA;HRAS;CAMK2B;KRAS;MAPK3;PPP1CC;PRKACB;MAPK1
gsea,cAMP signaling pathway,0.2715466029479214,1.2850179375325514,0.06581740976645435,0.28101516809880095,0.997,25/137,7.92%,RYR2;CACNA1C;GRIA3;GRIN2A;GRIA1;GRIN1;ATP2B4;GABBR2;GRIA4;ADCY8;ATP2B3;MAPK10;ADCY2;ROCK1;PDE10A;RAF1;CAMK2A;PIK3R3;CAMK2G;ADCY9;ADCYAP1R1;TIAM1;RAPGEF4;PDE4A;PIK3CD
gsea,mTOR signaling pathway,-0.2794094669678701,-1.2742110898823138,0.075046904315197,0.20178789049728027,1.0,48/119,31.70%,ATP6V1D;ATP6V1A;RPS6;ATP6V1G2;LAMTOR2;RHEB;RRAGA;ATP6V1F;LAMTOR3;HRAS;FZD3;RRAGD;KRAS;ATP6V1C1;SEC13;MAPK3;ATP6V1E1;ATP6V1B2;AKT1S1;CAB39;GSK3B;ATP6V1G1;MAPK1;TBC1D7;NRAS;WNT16;PIK3R2;RRAGC;WDR24;SEH1L;LAMTOR1;PIK3CB;FLCN;LAMTOR5;MAP2K1;TTI1;WNT5B;AKT3;RPS6KB1;GRB10;AKT1;PIK3R1;FZD8;PTEN;DDIT4;DVL1;FNIP2;CAB39L
gsea,Vascular smooth muscle contraction,0.301339493175582,1.2637592593622564,0.12127659574468085,0.30895190345642853,0.998,15/75,6.61%,PRKG1;CACNA1C;GUCY1A2;ADCY8;PRKCE;ADCY2;ROCK1;RAF1;PLA2G4E;PRKCG;KCNMA1;GNA12;ADCY9;PPP1R12B;KCNMB4
gsea,Endocytosis,-0.2599817449628803,-1.2561551059451452,0.07436399217221135,0.22183187060135864,1.0,52/203,21.58%,UBB;HSPA8;CLTA;ARF1;CAPZA2;VPS29;CDC42;AP2M1;ARPC5L;HSPA2;ARPC5;WASL;ARPC2;FGFR2;CHMP4B;PML;VPS28;ARF3;ARPC1A;CYTH2;SNX3;HRAS;ARPC3;RAB22A;TSG101;CHMP2A;SH3GLB1;RAB11A;ARF5;EHD3;CHMP6;RAB31;EPN1;H2-M5;AP2S1;CYTH4;VPS35;VPS4A;RUFY1;ARFGAP2;AP2B1;CHMP7;CHMP4C;STAM2;SNX4;RAB5A;SNX5;ACAP2;SH3GL2;RAB11B;SMAP1;RAB7
gsea,Glyoxylate and dicarboxylate metabolism,-0.3876744927760737,-1.255739918622866,0.18095238095238095,0.2202934273311219,1.0,4/24,5.58%,MDH2;MDH1;GLUL;MCEE
gsea,Peroxisome,-0.30376556194244075,-1.254112325700233,0.11397058823529412,0.22022838386940877,1.0,23/69,32.47%,ACSL3;PRDX5;SOD1;SCP2;PRDX1;MPV17;PEX12;PAOX;FAR2;PEX19;IDH2;NUDT19;MPV17L;CROT;ACOX1;MPV17L2;PEX5;PEX11B;GNPAT;SLC25A17;ABCD1;PMVK;ECH1
gsea,Pathways in cancer,-0.24763184002670263,-1.2527612814918436,0.05575539568345324,0.21996171620689664,1.0,67/322,19.65%,CALM1;CALM2;HSP90AB1;CALM3;GNAS;HSP90AA1;RAC1;JUN;ELOB;RASGRP1;GNB2;GSTM5;CTNNA3;CDC42;GNG2;VEGFC;GSTM1;BAX;FGFR2;CYCS;PDGFA;PML;RBX1;NFKB2;IFNGR2;GSTP1;HHIP;HRAS;GNAI1;GNG13;CEBPA;GNA11;VEGFB;ARHGEF1;CDK4;FZD3;RALA;CAMK2B;BAD;FGFR1;KRAS;GNAI2;GNG10;ITGAV;EPOR;MAPK3;ARNT2;DDB2;CKS2;GSK3B;GNG3;EPO;PRKACB;GNG7;JAG1;MAPK1;CDKN1B;HEY1;ELOC;RAD51;PDGFB;TXNRD1;CTNNA1;HSP90B1;NRAS;CCND3;WNT16
gsea,DNA replication,-0.37371524539433154,-1.2494169603173397,0.15818181818181817,0.2220406514390404,1.0,11/29,32.62%,PCNA;RFC3;RPA3;POLD4;RNASEH1;RNASEH2C;POLD2;RNASEH2A;MCM6;POLD3;PRIM1
gsea,Thyroid cancer,-0.37640535172866735,-1.2430510837578255,0.18806509945750452,0.2278310843614176,1.0,12/25,32.92%,BAX;HRAS;KRAS;MAPK3;DDB2;MAPK1;NRAS;MAP2K1;TPR;RXRB;CCND1;GADD45B
gsea,"Glycine, serine and threonine metabolism",-0.37518805971169117,-1.2381436521017593,0.17290552584670232,0.23226414112891242,1.0,6/26,18.14%,PGAM1;PHGDH;PGAM2;CHDH;PSAT1;GRHPR
gsea,Autophagy,-0.27577224580701387,-1.2333533617989099,0.12195121951219512,0.23626198457042047,1.0,45/117,31.12%,HMGB1;GABARAPL1;GABARAPL2;RHEB;RRAGA;CTSB;IRS2;PPP2CA;HRAS;LAMP1;GABARAP;ATG12;SH3GLB1;BAD;RRAGD;KRAS;SNAP29;MAPK3;ATG3;AKT1S1;PRKACB;MAPK1;NRAS;PIK3R2;RRAGC;RAB7;MRAS;CAMKK2;PIK3CB;NRBF2;MAP2K1;TRP53INP2;LAMP2;ATG9A;AKT3;RPS6KB1;AKT1;CTSL;ATG10;PIK3R1;PRKACA;PTEN;CFLAR;DDIT4;ITPR1
gsea,Small cell lung cancer,0.29333320155325693,1.232569780875778,0.12413793103448276,0.35553573865263427,1.0,21/65,20.89%,CHUK;RARB;TRAF3;LAMB1;PIK3R3;LAMB3;LAMC1;PTK2;IKBKB;PIK3CD;COL4A1;AKT2;POLK;ITGA3;FHIT;PIK3CA;BCL2;CDK6;COL4A2;PTGS2;NFKB1
gsea,Th17 cell differentiation,-0.3131467743640537,-1.2323860783469063,0.1420345489443378,0.2353986726468998,1.0,7/53,6.30%,HSP90AB1;PPP3CA;HSP90AA1;JUN;PPP3R1;PPP3CB;IFNGR2
gsea,Insulin resistance,0.2891197948909098,1.2215089341799354,0.14135021097046413,0.3684754654630827,1.0,15/71,12.91%,PRKCE;RPS6KA2;PRKAG2;MAPK10;PPARGC1B;PTPRF;PIK3R3;IKBKB;PYGB;MTOR;PIK3CD;SLC27A3;RPS6KA6;AKT2;RPS6KA1
gsea,Prostate cancer,-0.2920217324161772,-1.2166291243290854,0.1555977229601518,0.25350256982200575,1.0,22/70,23.88%,HSP90AB1;HSP90AA1;FGFR2;PDGFA;GSTP1;HRAS;BAD;FGFR1;KRAS;MAPK3;GSK3B;IL1R2;MAPK1;CDKN1B;PDGFB;HSP90B1;NRAS;CREB3L2;PIK3R2;NFKBIA;PIK3CB;MAP2K1
gsea,MicroRNAs in cancer,0.2722550844637086,1.2011408609223633,0.1271186440677966,0.4001385848553163,1.0,32/101,21.02%,PRKCE;NOTCH2;APC;DICER1;RPTOR;ZEB1;ROCK1;RAF1;PRKCG;CCND2;PLCG2;TNR;IKBKB;MTOR;ABCB1B;TRIM71;SOS1;APC2;RECK;DNMT1;MAPK7;EZH2;BCL2;ATM;DNMT3A;MMP16;ZFPM2;CDK6;PLCG1;PTGS2;NFKB1;ABL1
gsea,RIG-I-like receptor signaling pathway,0.33178081478333216,1.1944659810886609,0.226215644820296,0.4034437449832621,1.0,6/32,9.95%,CHUK;MAPK14;MAPK10;TRAF3;IKBKB;MAP3K7
gsea,Inositol phosphate metabolism,0.29599230686599404,1.190578324695777,0.19279661016949154,0.4010228138385955,1.0,19/64,17.78%,IPPK;INPP5A;PIP5K1B;OCRL;SYNJ1;PLCG2;ITPKB;PLCH1;PIKFYVE;MTMR1;PIK3CD;MTMR7;PLCE1;SYNJ2;INPP5B;ITPKC;PI4KA;INPP5J;PIK3CA
gsea,Fc gamma R-mediated phagocytosis,-0.2890753436127014,-1.1879361327882243,0.17928286852589642,0.29104724864628295,1.0,12/66,8.03%,RAC1;CFL1;CDC42;ARPC5L;MARCKSL1;MARCKS;ARPC5;WASL;ARPC2;CFL2;ARPC1A;ARPC3
gsea,Inflammatory bowel disease (IBD),-0.40797929854081894,-1.1866583952660887,0.24171539961013644,0.2906603423427131,1.0,3/16,6.30%,JUN;IL18;IFNGR2
gsea,Ribosome biogenesis in eukaryotes,-0.281229674745317,-1.1840666382489486,0.19488188976377951,0.2920542944184123,1.0,24/72,27.21%,RAN;SNU13;POP5;EMG1;NOP10;CSNK2B;EIF6;FBLL1;MPHOSPH10;GAR1;IMP3;RPP38;LSG1;FCF1;DKC1;POP4;RRP7A;GTPBP4;RPP25L;NOL6;WDR75;CSNK2A1;XRN1;NHP2
gsea,Purine metabolism,0.25511613090407187,1.1777581612490238,0.15536105032822758,0.41845882415033264,1.0,13/99,7.99%,PDE2A;GUCY1A2;PDE1A;PDE9A;AK5;ADCY8;PDE7B;ADCY2;PDE10A;PFAS;ADCY9;PDE4A;AK9
gsea,Central carbon metabolism in cancer,-0.3038994663495972,-1.1739316019878228,0.21912350597609562,0.30496467231186974,1.0,24/48,30.70%,PGAM1;PKM;FGFR2;LDHA;HRAS;SCO2;FGFR1;KRAS;PGAM2;MAPK3;SIRT6;PFKL;MAPK1;NRAS;HK1;PIK3R2;PIK3CB;MAP2K1;AKT3;AKT1;PIK3R1;PTEN;SLC2A1;PDHA1
gsea,Inflammatory mediator regulation of TRP channels,-0.30080495488941,-1.166086374514614,0.20486815415821502,0.31426795073764724,1.0,4/59,0.63%,CALM1;CALM2;CALM3;GNAS
gsea,Serotonergic synapse,-0.28094703046981934,-1.1617697749907254,0.20930232558139536,0.3182802631323599,1.0,17/68,16.37%,KCNJ3;GNAS;GNB2;GNG2;KCND2;HRAS;GNAI1;GNG13;KRAS;GNAI2;GNG10;SLC18A2;MAPK3;GNG3;PRKACB;GNG7;MAPK1
gsea,Ovarian steroidogenesis,0.35474042615765944,1.1617275290533804,0.24123711340206186,0.4436464697618192,1.0,7/23,12.67%,ADCY8;ADCY2;PLA2G4E;ADCY9;IGF1R;CYP2J6;ADCY6
gsea,Human papillomavirus infection,-0.23764404600533814,-1.155323385394903,0.1443661971830986,0.32587223708144775,1.0,45/207,20.10%,ATP6V0C;GNAS;ATP6V1D;ATP6V1A;UBE3A;ATP6V1G2;PKM;ATP6V0E2;CDC42;ATP6V0B;RHEB;BAX;PPP2R1A;ATP6V1F;PPP2CA;HRAS;VTN;CDK4;FZD3;BAD;TADA3;KRAS;PSMC1;ATP6V1C1;ITGAV;ITGA9;MAPK3;ATP6V1E1;ATP6V1B2;H2-M5;PPP2R5D;GSK3B;PRKACB;JAG1;ATP6V1G1;MAPK1;TBPL1;CDKN1B;HEY1;NRAS;CCND3;WNT16;TBK1;CREB3L2;PIK3R2
gsea,IL-17 signaling pathway,-0.3059202532742011,-1.151925022308745,0.24485981308411214,0.3289848889185322,1.0,11/44,19.71%,HSP90AB1;HSP90AA1;JUN;JUND;IL17RB;CEBPB;MAPK3;GSK3B;MAPK1;HSP90B1;TBK1
gsea,Nucleotide excision repair,-0.32186686261996367,-1.151729133244873,0.2326923076923077,0.32657299174539495,1.0,11/39,22.02%,CETN2;RBX1;PCNA;RFC3;RPA3;DDB2;POLD4;GTF2H5;ERCC3;GTF2H4;POLD2
gsea,Thyroid hormone signaling pathway,-0.2621407151039816,-1.150836083829092,0.20522388059701493,0.32534405374074843,1.0,18/98,16.37%,ATP1B1;ACTB;ACTG1;ATP1A1;ATP1A3;RHEB;ATP1B2;HRAS;MED4;BAD;KRAS;ITGAV;MAPK3;GSK3B;ATP1A2;PRKACB;RCAN1;MAPK1
gsea,NF-kappa B signaling pathway,0.2942706310210563,1.1479459148208433,0.2510822510822511,0.46319469402424285,1.0,15/46,20.89%,CHUK;TRAF3;PLCG2;CSNK2A2;LCK;IKBKB;MAP3K7;IL1R1;ERC1;MALT1;BCL2;ATM;PLCG1;PTGS2;NFKB1
gsea,Mannose type O-glycan biosynthesis,0.36330015814890426,1.1400685137817959,0.274703557312253,0.4708722872296564,1.0,8/20,23.52%,MGAT5B;LARGE1;ST3GAL3;B3GALNT2;POMGNT1;POMT2;CHST10;FKTN
gsea,Pancreatic secretion,-0.2937142352655578,-1.1390773308693036,0.2661596958174905,0.34211343287525553,1.0,9/50,10.61%,ATP1B1;GNAS;RAC1;ATP1A1;ATP1A3;ATP1B2;CCK;ATP2B1;RAB11A
gsea,Osteoclast differentiation,-0.26440809497632384,-1.1270448222771825,0.24564796905222436,0.3590487871609753,1.0,10/78,6.30%,PPP3CA;RAC1;JUN;SQSTM1;JUND;JUNB;PPP3R1;PPP3CB;NFKB2;IFNGR2
gsea,Chronic myeloid leukemia,0.2724671196104491,1.1261316120658602,0.23689727463312368,0.491931090395038,1.0,13/65,12.08%,TGFBR1;CHUK;BCR;RAF1;CBL;GAB2;PIK3R3;HDAC1;IKBKB;PIK3CD;SOS1;AKT2;POLK
gsea,Measles,-0.266225507174114,-1.1214614394146634,0.24587155963302754,0.3661289356255387,1.0,20/77,23.24%,RACK1;HSPA8;JUN;EIF3H;HSPA2;BAX;CYCS;CSNK2B;CDK4;BAD;NFKBIB;GSK3B;CDKN1B;RAB9;CCND3;TBK1;PIK3R2;JAK1;NFKBIA;PIK3CB
gsea,Fc epsilon RI signaling pathway,0.2904496976843764,1.119362520891549,0.27976190476190477,0.4955773634670619,1.0,11/45,12.06%,MAPK14;MAPK10;RAF1;PLA2G4E;GAB2;PIK3R3;PLCG2;PIK3CD;SOS1;AKT2;FYN
gsea,Lysosome,-0.2523182877098738,-1.1117221707828389,0.2682926829268293,0.38066997131531793,1.0,37/107,33.37%,ATP6V0C;LAPTM4A;PSAP;CLTA;ATP6V0B;CTSB;CTSO;ARSA;LAMP1;FUCA1;CD63;GUSB;AP3S2;AGA;AP3M1;DNASE2A;CLN5;NAGA;M6PR;CLTB;GBA;ACP2;ATP6AP1;LAMP2;AP1S1;AP3M2;CTSL;ARSG;LITAF;CTNS;GM2A;SMPD1;IDS;AP1M1;HYAL1;AP1S2;CTSD
gsea,Platelet activation,-0.26594214085371315,-1.1068009728144172,0.27695167286245354,0.38673463904938504,1.0,18/73,16.37%,ACTB;GNAS;ACTG1;RASGRP1;MYL12B;P2RY12;PPP1CA;GNAI1;ARHGEF1;GNAI2;TLN1;MAPK3;LYN;MYLK3;PPP1CC;PRKACB;VASP;MAPK1
gsea,Phosphatidylinositol signaling system,0.25561655092389296,1.0957516562031915,0.30039525691699603,0.540364767682048,1.0,19/85,8.86%,DGKG;DGKH;IPPK;INPP5A;PRKCG;PIP5K1B;OCRL;PIK3R3;SYNJ1;PLCG2;DGKB;ITPKB;PIKFYVE;DGKQ;PPIP5K1;MTMR1;PIK3CD;DGKI;MTMR7
gsea,"Alanine, aspartate and glutamate metabolism",-0.3212248551046979,-1.0945133414559451,0.31976744186046513,0.4052741255114037,1.0,16/28,43.89%,GLUL;NIT2;GOT2;CAD;GFPT2;NAT8L;ALDH5A1;GPT;ADSS;GLS;IL4I1;ASPA;GAD1;GOT1;GLUD1;GLS2
gsea,Insulin signaling pathway,-0.24659318445770326,-1.0911562508856065,0.27218934911242604,0.40789812640569106,1.0,18/106,15.12%,CALM1;CALM2;CALM3;RPS6;RHEB;IRS2;PPP1CA;HRAS;BAD;KRAS;PRKAR1B;MAPK3;PTPN1;GSK3B;PHKG1;G6PC3;PPP1CC;PRKACB
gsea,Th1 and Th2 cell differentiation,0.2809569568510701,1.0905962296416842,0.31185031185031187,0.5418822917746863,1.0,8/45,6.76%,MAML2;NOTCH2;CHUK;MAPK14;MAPK10;JAK2;LCK;IKBKB
gsea,Ubiquitin mediated proteolysis,0.23900395144261832,1.087728710146264,0.2876984126984127,0.5373357089081973,1.0,13/122,4.85%,UBE2E2;UBR5;PRKN;HUWE1;CDC27;TRIP12;HERC1;HERC2;BIRC6;CBL;UBE4A;UBE3C;PIAS2
gsea,Ras signaling pathway,-0.23470790372587155,-1.085835221757733,0.2796116504854369,0.41448170183208516,1.0,31/156,16.78%,CALM1;CALM2;CALM3;RAC1;RASAL2;RASGRP1;GNB2;BDNF;CDC42;ETS2;GNG2;VEGFC;FGFR2;PDGFA;ANGPT2;HRAS;GNG13;VEGFB;RALA;BAD;FGFR1;KRAS;GNG10;MAPK3;RASA1;TEK;GNG3;PRKACB;GNG7;MAPK1;FOXO4
gsea,Homologous recombination,-0.3167307324962577,-1.074705640648809,0.3623445825932504,0.43171002949760906,1.0,10/32,22.02%,SEM1;RPA3;POLD4;XRCC2;RAD50;RAD51;SYCP3;BABAM2;UIMC1;POLD2
gsea,Transcriptional misregulation in cancer,-0.2468449965739818,-1.0735493154349693,0.3135755258126195,0.4308240336165907,1.0,23/100,21.09%,DDX5;H3F3B;H3F3A;TSPAN7;MEF2C;BAX;PDGFA;PML;EYA1;CEBPA;CEBPB;ARNT2;DDB2;ELK4;ETV1;EWSR1;IL1R2;CDKN1B;SS18;BMP2K;WNT16;PBX1;CSF1R
gsea,Regulation of lipolysis in adipocytes,0.28465875140570507,1.0695536452966545,0.31875,0.5714072761133074,1.0,13/37,17.84%,PRKG1;ADCY8;ADCY2;PIK3R3;ADCY9;PIK3CD;AKT2;ADCY6;MGLL;PRKG2;ABHD5;PIK3CA;ADCY5
gsea,Chemical carcinogenesis,-0.3386681825076338,-1.0684130571767698,0.381651376146789,0.4371320578881019,1.0,8/23,26.96%,GSTM5;GSTM1;GSTP1;HPGDS;CBR1;ADH5;GSTM7;GSTO1
gsea,Steroid biosynthesis,-0.36397317415607333,-1.0652429498076421,0.37351778656126483,0.44003524773106023,1.0,3/15,8.91%,SQLE;MSMO1;EBP
gsea,T cell receptor signaling pathway,-0.259699885247304,-1.058289569148258,0.33204633204633205,0.4504444471727219,1.0,22/64,24.96%,PPP3CA;JUN;RASGRP1;CDC42;PPP3R1;PPP3CB;NCK1;HRAS;CDK4;KRAS;MAPK3;NFKBIB;GSK3B;MAPK1;BCL10;NRAS;PIK3R2;NFKBIA;PIK3CB;MAP2K1;CD247;MAP3K8
gsea,Chemokine signaling pathway,-0.23372675884852007,-1.0551628992437077,0.32884615384615384,0.45310718105062964,1.0,24/107,16.37%,RAC1;GNB2;CDC42;GNG2;WASL;HRAS;GNAI1;CCL27A;GNG13;BAD;KRAS;CX3CL1;CXCR6;GNAI2;GNG10;MAPK3;LYN;NFKBIB;GSK3B;GNG3;PRKACB;HCK;GNG7;MAPK1
gsea,Mismatch repair,-0.34690819914883125,-1.0535310007219485,0.36727272727272725,0.45284308771512644,1.0,8/19,31.63%,PCNA;RFC3;RPA3;POLD4;POLD2;MLH1;MLH3;POLD3
gsea,Melanoma,-0.27441784226558774,-1.049028101012166,0.384180790960452,0.4583562323040232,1.0,21/46,31.11%,BAX;PDGFA;HRAS;CDK4;BAD;FGFR1;KRAS;MAPK3;DDB2;MAPK1;PDGFB;NRAS;PIK3R2;FGF5;PIK3CB;MAP2K1;AKT3;AKT1;PIK3R1;PTEN;CCND1
gsea,Proteoglycans in cancer,-0.22795169538401167,-1.0312777475080066,0.3639705882352941,0.4893696886906554,1.0,23/129,15.18%,ACTB;DDX5;RAC1;ACTG1;RPS6;CDC42;TIMP3;PPP1CA;ANK1;HRAS;VTN;ARHGEF1;FZD3;CAMK2B;CD63;FGFR1;KRAS;ITGAV;MAPK3;EZR;PPP1CC;PRKACB;RDX
gsea,Leishmaniasis,-0.3016927925259455,-1.0272633438465173,0.4046242774566474,0.49358634855617883,1.0,9/30,22.50%,JUN;MARCKSL1;IFNGR2;MAPK3;NFKBIB;MAPK1;JAK1;TGFB2;NFKBIA
gsea,Focal adhesion,0.21697191209813177,1.01805504519699,0.40208333333333335,0.6986777067804284,1.0,26/131,12.06%,FLNB;PAK3;MAPK10;ROCK1;RAF1;THBS3;LAMB1;TLN2;PRKCG;PIK3R3;CCND2;ACTN4;LAMB3;TNR;LAMC1;PPP1R12B;PTK2;IGF1R;PARVB;FLNA;PIK3CD;RELN;SOS1;COL4A1;AKT2;FYN
gsea,Cytosolic DNA-sensing pathway,-0.292364502168738,-1.0179533602000974,0.43423423423423424,0.5089244357419572,1.0,10/32,22.50%,POLR2F;IL18;POLR2E;POLR3D;NFKBIB;POLR3H;POLR2L;TBK1;POLR3A;NFKBIA
gsea,Chagas disease (American trypanosomiasis),-0.25207969115884354,-1.0157944256713771,0.42940038684719534,0.5097911949711319,1.0,10/58,12.46%,GNAS;JUN;CALR;PPP2R1A;PPP2CA;IFNGR2;GNAI1;GNA11;GNAI2;MAPK3
gsea,Complement and coagulation cascades,-0.3398974239694234,-1.0155447955712065,0.44947735191637633,0.5068428002487032,1.0,3/18,10.78%,VTN;CLU;MASP2
gsea,"Parathyroid hormone synthesis, secretion and action",-0.2468812920374764,-1.0084130000356049,0.41865079365079366,0.5174164157830894,1.0,14/66,16.37%,GNAS;NACA;MEF2C;JUND;EGR1;GNAI1;GNA11;ARHGEF1;FGFR1;GNAI2;MAPK3;NR4A2;PRKACB;MAPK1
gsea,Cytokine-cytokine receptor interaction,-0.24251465012090606,-1.0035156430617125,0.4306569343065693,0.5236383557561068,1.0,26/70,30.00%,IL18;IFNGR2;CCL27A;IL17RB;CX3CL1;INHBA;CXCR6;EPOR;IL1R2;EPO;CRLF2;IL27;CSF1R;CXCL12;BMPR2;TGFB2;IL10RB;IL13RA1;GDF10;IL1RAP;BMP6;BMP8B;ACKR4;ACVR1C;IL27RA;IL11RA1
gsea,VEGF signaling pathway,-0.26791486253220026,-0.9991160391375766,0.44510978043912175,0.5287992835152041,1.0,9/45,12.46%,PPP3CA;RAC1;CDC42;PPP3R1;PPP3CB;HRAS;BAD;KRAS;MAPK3
gsea,Cell adhesion molecules (CAMs),0.25229884414613457,0.9981525892610065,0.4311740890688259,0.742318750612605,1.0,12/63,12.85%,NLGN1;NTNG2;CNTNAP2;NEGR1;NECTIN1;NFASC;PTPRF;L1CAM;NEO1;ALCAM;CADM1;ITGA8
gsea,mRNA surveillance pathway,-0.2331819631538315,-0.9945146863282601,0.4827586206896552,0.5340301102755403,1.0,18/80,19.08%,CPSF2;PABPC4;WDR82;PPP2R1A;SAP18;PPP2CA;PPP1CA;MAGOH;RBM8A;PABPC1;PPP2R5D;PELO;PPP1CC;DDX39B;NCBP2;MAGOHB;UPF3A;SSU72
gsea,Pyrimidine metabolism,-0.2644518137644226,-0.9932124851701409,0.4725274725274725,0.5330771011475577,1.0,8/44,13.89%,NME7;NME2;DTYMK;UCKL1;NME4;TK2;CAD;NME1
gsea,Toll-like receptor signaling pathway,0.2501316723916641,0.9899299949827921,0.45824847250509165,0.7516917506375896,1.0,9/46,12.04%,CHUK;MAPK14;MAPK10;TRAF3;PIK3R3;IKBKB;PIK3CD;MAP3K7;AKT2
gsea,Propanoate metabolism,-0.2867428203605601,-0.9882192535329944,0.4572564612326044,0.5398878139192168,1.0,5/24,11.27%,MCEE;LDHA;ALDH6A1;SUCLG1;LDHB
gsea,JAK-STAT signaling pathway,0.2286865688699039,0.9859234500059127,0.4967741935483871,0.7485837829958456,1.0,19/75,17.82%,RAF1;PIAS2;PIK3R3;CCND2;JAK2;MTOR;PIK3CD;SOCS2;PTPN2;PIAS1;IL6RA;SOS1;SOCS7;AKT2;STAT2;CSF2RA;LIFR;PIK3CA;BCL2
gsea,Sphingolipid signaling pathway,0.2225074547338419,0.9833955155196081,0.48975409836065575,0.7420925414151776,1.0,17/98,12.06%,PRKCE;MAPK14;MAPK10;ROCK1;RAF1;SGMS1;GAB2;PRKCG;PIK3R3;GNA12;CERS4;PIK3CD;PPP2R2B;CERS6;MAP3K5;AKT2;FYN
gsea,Wnt signaling pathway,-0.22543336703896139,-0.9827008136204413,0.48919449901768175,0.5478419211019822,1.0,13/96,10.58%,PPP3CA;RAC1;JUN;CACYBP;CSNK1E;PPP3R1;PPP3CB;RBX1;CSNK2B;FZD3;TBL1XR1;RUVBL1;CAMK2B
gsea,AMPK signaling pathway,-0.22377100181822746,-0.9795665236604755,0.4876660341555977,0.5506683816436216,1.0,36/94,33.39%,RAB2A;EEF2;RHEB;PPP2R1A;IRS2;PPP2CA;SCD1;RAB14;AKT1S1;CAB39;PPP2R5D;G6PC3;PFKFB3;PFKL;SCD2;HMGCR;CREB3L2;PIK3R2;ADIPOR2;RAB11B;CAMKK2;FASN;PIK3CB;PFKFB1;CREB1;AKT3;CRTC2;RPS6KB1;PPP2R5B;AKT1;PIK3R1;CCND1;CAB39L;TSC2;FOXO3;PPP2R2D
gsea,AGE-RAGE signaling pathway in diabetic complications,-0.2378505590376733,-0.9766087026749645,0.4858757062146893,0.5532234573074205,1.0,11/64,12.46%,RAC1;JUN;CDC42;VEGFC;BAX;EGR1;HRAS;VEGFB;CDK4;KRAS;MAPK3
gsea,Endometrial cancer,-0.2504968527846632,-0.975925657666222,0.5298651252408478,0.551085940459287,1.0,24/49,33.93%,CTNNA3;BAX;HRAS;BAD;KRAS;MAPK3;DDB2;GSK3B;MAPK1;ILK;CTNNA1;NRAS;PIK3R2;PIK3CB;MAP2K1;MLH1;AKT3;AKT1;PIK3R1;PTEN;CCND1;GADD45B;FOXO3;ARAF
gsea,FoxO signaling pathway,0.21022759904638752,0.9636142706170933,0.5395256916996047,0.7846861465968206,1.0,13/100,7.92%,TGFBR1;CHUK;MAPK14;PRKAG2;MAPK10;RAF1;USP7;BCL6;PIK3R3;CCND2;IKBKB;IGF1R;PIK3CD
gsea,Hepatocellular carcinoma,-0.21240385763296257,-0.962557269542844,0.548689138576779,0.5757791959826966,1.0,42/120,31.66%,ACTB;ACTG1;GSTM5;GSTM1;BAX;GSTP1;HRAS;CDK4;FZD3;BAD;KRAS;MAPK3;DDB2;GSK3B;BRD7;MAPK1;SMARCE1;TXNRD1;NRAS;WNT16;PIK3R2;SMARCB1;ACTL6B;TGFB2;KEAP1;PIK3CB;MAP2K1;GSTM7;WNT5B;CSNK1A1;AKT3;GSTO1;RPS6KB1;SMAD4;AKT1;PIK3R1;SMAD2;FZD8;PTEN;CCND1;DVL1;GSTM6
gsea,Acute myeloid leukemia,0.24787792624594712,0.9623921269826438,0.5175983436853002,0.7739385226790069,1.0,11/46,13.07%,CHUK;RAF1;PIK3R3;FLT3;IKBKB;MTOR;PIK3CD;SOS1;PPARD;AKT2;RUNX1T1
gsea,TGF-beta signaling pathway,-0.23716407525766522,-0.9599053227028549,0.5229007633587787,0.5775506932997516,1.0,21/56,29.76%,PPP2R1A;RBX1;PPP2CA;INHBA;MAPK3;BAMBI;NBL1;MAPK1;ID4;BMPR2;TGFB2;E2F4;SMAD7;FST;SMAD9;BMP6;RPS6KB1;BMP8B;SMAD4;ACVR1C;SMAD2
gsea,Natural killer cell mediated cytotoxicity,-0.2457183421456603,-0.949819250739292,0.525,0.5935390879110423,1.0,8/53,12.46%,PPP3CA;RAC1;PPP3R1;PPP3CB;IFNGR2;HRAS;KRAS;MAPK3
gsea,Relaxin signaling pathway,-0.21709890865458314,-0.9421505726789452,0.5828571428571429,0.6056539436138275,1.0,34/88,30.34%,GNAS;JUN;GNB2;GNG2;VEGFC;HRAS;GNAI1;GNG13;VEGFB;KRAS;GNAI2;GNG10;MAPK3;GNG3;PRKACB;GNG7;MAPK1;ATF2;NRAS;CREB3L2;PIK3R2;NFKBIA;PIK3CB;MAP2K1;GNG11;CREB1;AKT3;GNB4;AKT1;ARRB1;PIK3R1;PLCB1;SMAD2;PRKACA
gsea,Tryptophan metabolism,0.2852693484533448,0.9369751967963907,0.5515789473684211,0.8307322904657665,1.0,20/21,61.79%,ACAT1;ALDH7A1;DHTKD1;CAT;DLD;KYAT1;ALDH3A2;HADHA;TDO2;AFMID;KYAT3;MAOA;DLST;ECHS1;ALDH9A1;HADH;ACAT2;KMO;ALDH2;IL4I1
gsea,One carbon pool by folate,-0.3052644371824893,-0.9098351374132068,0.5942028985507246,0.6692554430212887,1.0,4/18,23.27%,ATIC;DHFR;ALDH1L1;MTHFD2
gsea,N-Glycan biosynthesis,0.23238955323030575,0.905823698482961,0.6217391304347826,0.902313081688113,1.0,9/48,13.34%,MAN2A1;MAN1C1;MGAT5B;MAN2A2;MAN1A2;ALG8;ALG12;MGAT5;MGAT4C
gsea,Longevity regulating pathway,0.20401325649681856,0.9054400228384589,0.6548323471400395,0.8878530153683573,1.0,17/85,13.85%,ADCY8;PRKAG2;RB1CC1;RPTOR;EHMT1;ADCY2;PIK3R3;HDAC1;ADCY9;IGF1R;MTOR;PIK3CD;KL;AKT2;ADCY6;EHMT2;CLPB
gsea,Notch signaling pathway,0.24473147531155498,0.9016018777955266,0.6183368869936035,0.883804967624001,1.0,16/40,28.45%,MAML2;NOTCH2;HDAC1;MAML3;DTX1;ADAM17;DVL3;PSEN1;RBPJ;NUMBL;NCOR2;APH1C;DLL1;DLL4;PSEN2;EP300
gsea,Amoebiasis,0.2414409533379056,0.8988125441290771,0.584,0.8764871325731586,1.0,8/41,7.92%,LAMB1;PRKCG;PIK3R3;ACTN4;LAMB3;LAMC1;PTK2;PIK3CD
gsea,Hematopoietic cell lineage,0.2557826984178047,0.8942014433219435,0.6086021505376344,0.8746686577108955,1.0,9/28,19.34%,GYPA;FLT3;IL6RA;IL1R1;ITGA3;KITL;CSF2RA;ITGA4;KIT
gsea,Bladder cancer,-0.26707810189498493,-0.8941512625788187,0.6127167630057804,0.6976507688022714,1.0,7/26,23.88%,HRAS;CDK4;KRAS;MAPK3;MAPK1;NRAS;MAP2K1
gsea,Basal cell carcinoma,0.2549770989238832,0.8918928634377998,0.6367924528301887,0.8664162846997893,1.0,8/30,15.35%,APC;AXIN1;SUFU;SMO;APC2;POLK;DVL3;AXIN2
gsea,Fatty acid elongation,-0.260375967576421,-0.8844336392887654,0.6146616541353384,0.7132280227119508,1.0,16/27,49.67%,TECR;HACD4;HSD17B12;ACOT3;THEM4;ACOT2;ACOT1;PPT1;ACAA2;ACOT4;HADH;ELOVL2;ELOVL4;ECHS1;ACOT5;PPT2
gsea,Gastric cancer,0.1975302047628545,0.877549587237581,0.7384259259259259,0.8892252057704405,1.0,14/90,12.08%,TGFBR1;FGF10;APC;RARB;RAF1;PIK3R3;MTOR;PIK3CD;ABCB1B;AXIN1;SOS1;APC2;AKT2;POLK
gsea,Toxoplasmosis,0.21281731653841313,0.8756164711857866,0.688659793814433,0.8800718585617668,1.0,11/61,12.04%,CHUK;MAPK14;MAPK10;LAMB1;LAMB3;LAMC1;JAK2;IKBKB;MAP3K7;GNAO1;AKT2
gsea,TNF signaling pathway,0.209798617909069,0.8643002710847711,0.7254098360655737,0.8943745900259116,1.0,11/63,12.04%,CHUK;MAPK14;MAPK10;TRAF3;PIK3R3;IKBKB;PIK3CD;MAP3K7;DAB2IP;MAP3K5;AKT2
gsea,Ether lipid metabolism,0.251303579455347,0.8617482025543634,0.6681514476614699,0.8869732711174211,1.0,15/27,34.99%,PLA2G4E;AGPS;ENPP2;PLA2G3;GAL3ST1;GDPD1;PLA2G12A;SELENOI;PAFAH2;CEPT1;LPCAT1;LPCAT2;GDPD3;PLB1;UGT8A
gsea,Pancreatic cancer,-0.20461904742531808,-0.8605458425712255,0.7289719626168224,0.7571214484512053,1.0,22/65,29.76%,RAC1;CDC42;BAX;CDK4;RALA;BAD;KRAS;MAPK3;DDB2;MAPK1;RAD51;PIK3R2;JAK1;TGFB2;PIK3CB;MAP2K1;AKT3;RPS6KB1;SMAD4;AKT1;PIK3R1;SMAD2
gsea,Signaling pathways regulating pluripotency of stem cells,0.19401374979778938,0.8564728460902927,0.7674897119341564,0.8859108905435251,1.0,17/85,15.35%,APC;MAPK14;RAF1;PAX6;PIK3R3;JAK2;IGF1R;PIK3CD;SETDB1;AXIN1;ONECUT1;APC2;AKT2;ACVR1B;RIF1;DVL3;AXIN2
gsea,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.25304698382060803,-0.8556027991205878,0.716796875,0.7626130520194664,1.0,5/25,16.31%,PIGK;PIGYL;PIGF;DPM2;PIGH
gsea,Breast cancer,0.1930376428154722,0.8498078876502789,0.7819383259911894,0.8878445242245623,1.0,15/90,12.08%,FGF10;NOTCH2;APC;RAF1;PIK3R3;IGF1R;SP1;MTOR;PIK3CD;NCOA1;AXIN1;SOS1;APC2;AKT2;POLK
gsea,Cortisol synthesis and secretion,0.2242633389652382,0.8464889430832808,0.722567287784679,0.882247738155949,1.0,5/43,6.99%,CACNA1C;ADCY8;ADCY2;ADCY9;SP1
gsea,Nicotinate and nicotinamide metabolism,0.27022390048067907,0.8464652922930561,0.696969696969697,0.8696729039575447,1.0,7/19,27.88%,NNT;NUDT12;NT5C2;NMNAT2;NMRK1;NT5E;NT5C3
gsea,Cushing syndrome,0.18810579832211805,0.8421033736592071,0.8034934497816594,0.8664990564157974,1.0,19/102,15.69%,CACNA1C;ADCY8;APC;ADCY2;KMT2A;CAMK2A;CAMK2G;ADCY9;SP1;AXIN1;PDE11A;APC2;ADCY6;CAMK2D;ARNT;CACNA1H;DVL3;AXIN2;ATF6B
gsea,Adipocytokine signaling pathway,0.2091000102226178,0.8417438041381927,0.7564655172413793,0.8551434312412193,1.0,6/48,7.79%,CHUK;PRKAG2;MAPK10;JAK2;IKBKB;MTOR
gsea,Colorectal cancer,-0.19893704345177549,-0.833006912182897,0.7847619047619048,0.8013480220558242,1.0,25/72,29.76%,RAC1;JUN;BAX;CYCS;HRAS;RALA;BAD;KRAS;MAPK3;DDB2;GSK3B;MAPK1;NRAS;PIK3R2;TGFB2;PIK3CB;MAP2K1;MLH1;AKT3;BBC3;RPS6KB1;SMAD4;AKT1;PIK3R1;SMAD2
gsea,Arachidonic acid metabolism,0.2565883530718968,0.8286660803704284,0.7278761061946902,0.8689542324233288,1.0,7/20,20.68%,LTA4H;PLA2G4E;CYP2J6;PLA2G3;CYP2U1;CYP4F13;PTGS2
gsea,Glycosaminoglycan biosynthesis,0.2131262583620838,0.8236771155997784,0.7419354838709677,0.8668962849869177,1.0,14/45,22.78%,CHST11;EXT2;ST3GAL3;HS6ST3;HS2ST1;EXT1;EXTL3;XYLT2;XYLT1;HS3ST2;UST;ST3GAL2;B3GNT2;GLCE
gsea,Hepatitis B,-0.18844679765082378,-0.8215080275203329,0.811623246492986,0.8175898448325238,1.0,32/100,29.76%,JUN;YWHAB;BAX;CYCS;YWHAZ;HRAS;VDAC3;YWHAQ;PCNA;BAD;KRAS;MAPK3;DDB2;EGR3;MAPK1;ATF2;NRAS;TBK1;CREB3L2;PIK3R2;JAK1;TGFB2;NFKBIA;PIK3CB;MAP2K1;CREB1;ATP6AP1;AKT3;SMAD4;AKT1;PIK3R1;SMAD2
gsea,Basal transcription factors,-0.21826429806638822,-0.8204125826130902,0.803921568627451,0.8148209384815068,1.0,22/39,40.98%,GTF2B;TAF11;TAF10;TBPL1;GTF2H5;TAF5;ERCC3;GTF2H4;TAF7L;TAF12;TAF7;GTF2H3;TAF6L;GTF2A1;TBP;TAF13;CCNH;GTF2E1;TAF9B;TAF8;GTF2F1;GTF2F2
gsea,Other glycan degradation,0.2840128206765088,0.8170134464075195,0.72,0.8676437851907515,1.0,4/15,15.36%,HEXA;HEXB;MANBA;HEXDC
gsea,Terpenoid backbone biosynthesis,-0.25549280178248535,-0.8155214014448101,0.7338403041825095,0.8183945260951793,1.0,4/20,19.68%,HMGCS1;FDPS;HMGCR;PCYOX1
gsea,Non-small cell lung cancer,0.19974037132668504,0.806932487657742,0.8028747433264887,0.8734742912268091,1.0,20/57,24.91%,RARB;RAF1;PRKCG;PIK3R3;PLCG2;EML4;PIK3CD;SOS1;AKT2;POLK;FHIT;PIK3CA;STK4;CDK6;PLCG1;ALK;RASSF5;TGFA;EGF;RB1
gsea,beta-Alanine metabolism,-0.25521235683486926,-0.7771090624520267,0.793939393939394,0.8743100129211391,1.0,2/20,8.92%,SRM;ALDH6A1
gsea,Aminoacyl-tRNA biosynthesis,-0.20480936325961632,-0.7678754098321614,0.8518518518518519,0.881805830848957,1.0,12/42,28.96%,NARS;TARSL2;AARS;GATB;WARS2;FARS2;GATC;PARS2;TARS;EPRS;HARS;YARS2
gsea,Fanconi anemia pathway,0.19791180059482488,0.7659235972064317,0.8552915766738661,0.926525168888027,1.0,23/44,35.63%,POLK;CENPS;FANCM;ERCC4;PMS2;FANCD2;SLX4;FAN1;FANCL;EME2;RMI1;POLN;UBE2T;FAAP100;BLM;SLX1B;FANCB;FANCG;RPA2;FANCA;REV1;RAD51C;RPA1
gsea,Other types of O-glycan biosynthesis,0.23357293254919048,0.7512265379957557,0.8315789473684211,0.9342076933967679,1.0,20/20,76.68%,ST3GAL3;COLGALT2;POMT2;POFUT2;OGT;B4GALT1;B3GLCT;POFUT1;POGLUT1;EOGT;B4GALT3;COLGALT1;PLOD3;B4GALT2;ST6GAL2;GXYLT1;GXYLT2;ST6GAL1;RFNG;POMT1
gsea,Circadian rhythm,0.2215170896429527,0.7499722212534249,0.844758064516129,0.9239337985477799,1.0,3/27,5.48%,PRKAG2;RORA;ARNTL
gsea,Amino sugar and nucleotide sugar metabolism,-0.20179366967203782,-0.7415460128750846,0.8884540117416829,0.9094390294397605,1.0,12/39,28.70%,PMM1;CMAS;CYB5R3;NANP;GFPT2;HK1;GNPNAT1;AMDHD2;GNE;GALT;GNPDA1;UAP1
gsea,Herpes simplex virus 1 infection,0.14090905152863656,0.7412863666909093,0.9950124688279302,0.9226992599732088,1.0,50/283,18.05%,CHUK;ZFP950;POU2F2;TRAF3;NECTIN1;PIK3R3;ZFP568;JAK2;IKBKB;ZFP157;ZFP607A;ZFP951;MTOR;GM14391;PIK3CD;ZFP398;ZFP944;ZFP189;CFP;ZFP286;RBAK;ZFP9;MAP3K7;ZFP128;ZFP53;AKT2;ZFP382;ZFP810;ZFP667;ZFP52;ZFP40;STAT2;ZFP60;SRSF5;ZFP354A;ZFP472;SRSF6;ZFP949;HCFC2;ZFP963;ZFP948;GM14393;SRSF4;ZFP78;SRSF1;ZFP108;PIK3CA;BCL2;ZFP61;ZFP994
gsea,Butanoate metabolism,-0.24419667445186072,-0.7220208899732464,0.8249027237354085,0.9247934234315807,1.0,7/16,40.79%,HMGCS1;ALDH5A1;BDH1;OXCT1;HMGCLL1;ACAT2;GAD1
gsea,Sphingolipid metabolism,0.17194697552238913,0.6321114604093067,0.9714285714285714,0.9879358671682867,1.0,9/37,25.19%,SGMS1;CERS4;CERS6;GAL3ST1;SPTLC1;SGPL1;CERS5;ACER3;CERK
gsea,"Valine, leucine and isoleucine degradation",-0.16865055430523868,-0.6308307764382436,0.9731958762886598,0.9794995867699416,1.0,4/40,8.92%,MCEE;ACAD8;HMGCS1;ALDH6A1
gsea,Fatty acid degradation,-0.1817765641815406,-0.626689666959158,0.9509803921568627,0.9754555182355914,1.0,1/28,1.36%,ACSL3
gsea,Galactose metabolism,0.19972103140597836,0.6234591334972956,0.9558232931726908,0.9787303558009606,1.0,1/20,1.16%,GCK
